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Chapter 1: Introduction
Cardiovascular disease (CVD) is the leading cause of death in the United States
and industrialized countries, with Coronary Heart Disease (CHD) as its major
manifestation [1]. Despite an approximate 29% decline in death rate between 1996 and
2006, CVD accounted for about 34% deaths in 2006. CHD is a major health concern
causing approximately one in every six deaths reported in 2006. It is estimated in the
year 2010, 785,000 Americans will have first cardiac arrest and about 470,000 will
experience recurrent attacks [2]. CVD can be described as chain of events that is
initiated by a cluster of risk factors, progressing through physiological pathways of
atherosclerosis, CHD, myocardial infarction, arrhythmia, leading to congestive heart
failure, sudden death and development of end stage heart disease [3].
Besides age, gender and genetics that are identified as non-modifiable risk
factors, modifiable risk factors can be divided into two main categories : Risk factors
that have direct causal association to the development and progression of CHD,
namely, dyslipidemia, hypertension, elevated blood glucose levels and tobacco
consumption; and risk factors that have significant impact on the direct risk factors
predisposing them to development of the disease which include physical inactivity,
obesity and atherogenic diet [4, 5]. Emerging risk factors have been identified and are
being studied to understand their role in the progression of the disease including LDL
and HDL particle sizes, Lp(a), markers of LDL and HDL (Apo B-100 and Apo A1
respectively) and Total and LDL cholesterol to HDL cholesterol ratios [6]. Prospective
data shows that clustering of greater than 3 risk factors increases the relative risk 2.4
folds in men and about 6 folds in women for [7]. Comprehensive therapeutic risk factor
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modifications need to be made to prevent or delay the onset and progression of CHD.
These include dietary modifications, increase physical activity, smoking cessation and
weight management.

Plasma Cholesterol is implicated in the pathology of CVD
Elevated plasma cholesterol levels have been established as a key biomarker in
categorizing an individual’s risk for CVD. High levels of total cholesterol (TC), LDLcholesterol (LDL-C), small dense LDL particles and triglycerides (TG) along with low
levels of HDL-cholesterol (HDL-C) are characteristic to a dyslipidemic profile. The
current National Cholesterol Education Program (NCEP) guidelines suggest target
levels of TC, LDL-C and HDL-C for determining an individual’s risk status and in
evaluating the efficacy of lipid lowering therapies [6]. Although most of the nutritional
and pharmaceutical research has kept their emphasis primarily on attenuating the risk
for CVD by lowering TC and LDL-C, raising HDL-C is becoming an important
therapeutic focal point.
Elevated TC and LDL-C is one of the primary risk factors involved in the onset
and progression of atherosclerosis. Prospective studies reveal a higher and positive
correlation of CHD, CVD and mortality at higher cholesterol levels. Positive relationship
between cholesterol levels and first or subsequent attacks of CHD have been observed
over a range of LDL-C levels [6, 8, 9]. Also, cholesterol levels in young adults seem to
be indicative of development of CHD later in life. In a tri cohort prospective study,
Stamler et al concluded that CVD in middle age is positively linked to high levels of
baseline TC in young adulthood [10]. The relationship of elevated LDL-C to
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development of CHD is mediated by atherosclerosis, a process that begins much earlier
in life than the actual disease. Oxidized LDL-C could either initiate the process of
atherosclerosis by causing an injury to the endothelial lining or have an impact due to its
role in proliferation and formation of fatty atherosclerotic plaques [6, 11]. Due to such
strong associations, reduction of TC and LDL-C has been the primary therapeutic
targets. Depending on the level and associated risk factors, strategies to lower TC
include weight loss, diet modifications and/or pharmaceutical intervention of HMGCoA
reductase inhibitors (statins) and bile acid resins [11].
An emerging area of interest is the association of total LDL particle number and
LDL particle size with CHD. Studies suggest that small LDL particles and increased LDL
particle number are positively associated with CVD endpoints [12, 13]. One of the
reasons for increased atherogenic propensity of small LDL particles could be higher
susceptibility to oxidation in relation to lipid-poor large particles [14]. Another plausible
mechanism suggested for the above relationships is lower affinity for LDL receptors for
small LDL particles compared to midsize particles [15]. More research is needed to
determine clinical manifestations of size and number of LDL particles before they can
be used as routine biomarkers.
HDL-C concentrations have been identified as an independent risk factor for
CVD. HDL scavenges cholesterol from the peripheral tissues and delivers it back to the
liver for excretion or repackaging via Reverse Cholesterol Transport. Prospective
studies suggest inverse relationship between HDL-C concentrations and CVD risk,
independent of LDL concentrations. Gordon et al evaluated multiple cohort groups and
reinstated the inverse relationship between CHD event rates and HDL-C [16]. Due to

4
this relationship HDL-C is an important factor to consider while assessing the overall
risk for CVD. There is evidence that small HDL particle size may have an
atheroprotective effect mediated through prevention of LDL oxidation [17]. HDL
therefore has a potential for therapeutic interventions.
LDL-C concentrations have been used as the primary index of CVD risk
assessment and target for therapy. However, atherogenic indices, TC:HDL and
LDL:HDL cholesterol ratios are thought to be more sensitive in assessing the risk than
considering TC, LDL or HDL alone. An increase in the ratio could be indicative of either
an increase in TC or LDL or decrease in HDL-C. For CVD risk standpoint, the ratios
should be lower for decreased risk. In the following segments in assessing the effects of
various fatty acids on CVD risk, TC:HDL-C ratio will be considered for risk assessment.

Modification of an atherogenic diet attenuates the risk for CVD
Modifications in an atherogenic diet pattern is considered cornerstone in the
prevention as well as progression of CVD. AHA dietary guidelines suggest that a diet
high in fruits, vegetables, whole grains and unsaturated fatty acids have lower
associations with CVD risk factors compared to an atherogenic diet. In context of fatty
acids, a diet high in saturated fatty acids (SFA), trans fatty acids (tFA) and cholesterol
along with low intakes of Unsaturated fatty acids is considered atherogenic [18].
A Fatty acid (FA) is a carboxylic acid with a saturated or unsaturated hydrocarbon
chain. Most naturally occurring FA have a chain length between 4 and 28. Saturated
fatty acids (SFA) are linear carbon chain molecules fully saturated with hydrogen atoms.
Owing to its saturated configuration with no double bonds, they are solid at room
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temperature and have a high melting point. The major types of dietary SFA are Lauric
acid (12:0), Myristic Acid (14:0), Palmitic Acid (16:0) and Stearic Acid (18:0). In the
American diet, full fat dairy and red meats constitute the major sources of SFA with a
smaller portion from plant sources such as coconut, palm, cocoa and Shea nut oils.
Monounsaturated fatty acids (MUFA) have one point of unsaturation in the hydrocarbon
chain. The main dietary sources of MUFA include olive oil, canola oil, avocados, nuts
and seeds. Polyunsaturated fatty acids (PUFA) have two or more points of unsaturation
on the hydrocarbon chain. The main dietary sources include fish, soybean, sunflower
and safflower oil. Trans fatty acids (tFA) are unsaturated fatty acids with atleast one
double bond in trans configuration. They are present at low levels (~5%) in meats and
dairy products formed due to bacterial fermentation in ruminant animals. The
independent effects of SFA and tFA in relation to their replacement with unsaturated
fatty acids on plasma cholesterol levels and CVD risk factors are considered below.
Consumption of SFA has been the center of controversy for the last 60 years.
Consumption of dietary SFA has been linked with elevated concentrations of total
cholesterol and LDL-C, markers for increased risk for CVD which led to the basis for the
diet-heart hypothesis. The current guidelines for SFA consumption is <7 % of total
energy (AHA) and <10% of total energy (USDA) [19-21]. Dietary and policy
recommendations often focus on reducing SFA consumption for improving the CVD risk
factors based on ecological and animal studies [22]. Most individual prospective cohort
studies have not established an independent relationship between SFA consumption
and CHD incidence [23, 24]. In an assessment of 11 prospective studies across 3
continents analyzed for 4-10 year follow up, SFA was associated with higher CHD only
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in comparison to PUFA. The effects of SFA are studied in relation to other fatty acids or
macronutrients. Consumption of CHO and MUFA were also associated with trends
towards higher risk for CHD [25]. Replacement of SFA with MUFA or PUFA has been
shown to decrease LDL-C as well as HDL-C, with equal effects in reducing TC:HDL
ratio in free living young adults. [26]. Interestingly, effect of SFA on LDL-C is mediated
by the presence and amount of PUFA in the diet. If PUFA is less than 5% of the total
energy, SFA increase LDL-C. Conversely, if PUFA is greater than 5% of total energy,
the effect of SFA is negated [27]. In a clinical trial, LDL, TC and apoB were not different
between women who consumed diets high or low in SFA with similar P:S ratio [28].
An adverse lipid profile includes elevation of LDL-C specifically small dense LDLC particles. Interestingly, SFA increases LDL-C but increases the large LDL particles
and not the small dense LDL particles [20, 29]. In a meta-analysis by Siri-Tarino et.al,
associations of SFA on CHD and CVD were analyzed. In a 5-23 year follow up of 16
cohorts, they concluded that there was no significant effect of dietary SFA on CHD,
stroke or CVD [23]. In a meta-analysis of 60 controlled trials by Mensink et al, the
effects of various dietary SFA were compared in reference to carbohydrates which
revealed that Lauric and Myristic fatty acids tend to increase LDL-C compared with
Palmitic acid while Stearic acid is considered neutral [30]. A recent review elucidated
the effects of SFA consumption and CVD risk. The authors noted that replacement of
SFA with MUFA and PUFA decreases the TC/HDL-C ratio while the ratio increases
when SFA are replaced with tFA [22].
In the United States, partially hydrogenated vegetable oil (PHVO) is the main
source of tFA in the food supply (~30-50%) [31]. Partial hydrogenation is a process of
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transforming liquid oil into a semi solid or solid state. The process involves introduction
of hydrogen into the oil in presence of a nickel catalyst. This saturates the double bonds
and in the process forms some metastable intermediates which allow the double bonds
to rotate and form the trans configuration. Alterations in temperature, pressure and
stirring speed can change the melting range, stability and mouth feel of the
hydrogenated oil. PHVO in the food supply come from processed food products that
require solid fats e.g. margarines, baked goods and shortenings containing 30-50% tFA
[32-35].
Although PHVO was being used in small quantities, its production and usage
increased after 1960s as a replacement response to health recommendations to reduce
SFA in the diet. Initial studies conducted to evaluate the health implications of tFA
showed inconclusive results. Mensink et al (1990) conducted a human study with 59
healthy subjects and compared the effects of consumption of 10.9% total energy from
either tFA, SFA or MUFA. The results from the study concluded that consumption of tFA
and SFA resulted in similar increases in LDL-C compared to MUFA, but HDL-C was
lowered in case of tFA compared to SFA and MUFA suggesting a higher
cholesterolemic effect of tFA compared to SFA [36]. Judd et al compared the effects of
diets containing oleic acid, 3.8% tFA, 6.6% tFA or SFA in 58 healthy subjects. Results
from the study showed similar increases in LDL-C for tFA diet groups and SFA
compared to oleic acid diet. HDL-C was highest in case of SFA diet and lowest for diet
with highest percentage of tFA [37].
Lichtenstein et al compared the effects of diets with increasing percentage (0.9%
- 6.7%) of trans fatty acids in margarines to soybean oil and butter diets in 36 subjects
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in a randomized double blinded crossover study. The study results revealed that
increasing tFA consumption linearly increased LDL-C. HDL-C remained unchanged at
lower intakes [32] of tFA, but at highest intake (6.7%), HDL-C was significantly lower
compared to butter. TC:HDL ratio increased linearly being least favorable at highest
consumption of tFA suggesting higher risk for CHD with increasing amounts of tFA in
the diet. Mauger et al conducted a human study to investigate the effect of tFA on LDLC particle sizes relative to SFA. The results from the study concluded that consumption
of tFA increased the harmful small dense LDL-C particles leading to an increased risk
for CVD. For the SFA diet, the large LDL-C particles increased as opposed to the small
dense particles in tFA diet. The data shows that tFA are more deleterious to health
compared to SFA[29].
Results of prospective epidemiological studies also support the changes reflected
in the controlled trials. The Nurses’ Health study is a longitudinal research initiated in
1976 with 121,700 female registered nurses, to investigate the relation of diet and
lifestyle on chronic diseases. Ascertainment of their dietary habits, lifestyle and disease
is made every 2 years by mailed questionnaires. In a 8 year follow up by Willett et.al,
there was no association observed for CHD risk with the consumption of red meats
containing ruminant tFA, as opposed to a strong association with consumption of
margarine and cookies in which the primary form was trans elaidic acid predominantly
present in PHVO [38]. In a 14 year follow up Hu et.al showed that SFA and MUFA were
not significantly related to the risk of CHD, PUFA was inversely related to the risk of
CHD from the lowest to the highest consumption and tFA was directly related to the risk
for CHD. The analysis also revealed that with 1.6% increase in total energy from tFA the
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relative risk for CHD increased by 53% [39]. Also during the 14 year follow up Salmeron
et al assessed the impact of dietary fatty acids on risk for Diabetes Mellitus II (DM II).
The analyses showed that tFA increased the risk for DM II linearly with increased
consumption. Replacing 5% energy from SFA with PUFA decreased the RR by 35% in
comparison with replacing 2% energy of tFA with PUFA, decreased the RR by 40%
suggesting an increased risk for DM II with tFA consumption [40]. In the most recent
meta-analysis of 20 year follow up Oh et al reinstated that PUFA intake was related to
decreased risk of CHD and tFA intake was associated with an increased risk for CHD
specially in women younger than 65 years [41]. In the Health Professionals study,
Ascherio et al also concluded that a positive relationship existed between the
consumption of tFA and CHD risk. The risk increased by 40% after adjusting for
multivariates [42].
In a recent meta-analysis by Mozaffarian et al, effects of tFA on blood lipids and
lipoproteins were analyzed and the association of habitual consumption of tFA with
CHD was studied. The analysis showed that compared with equivalent kcalories from
other fats (SFA, MUFA and PUFA), tFA increased TC/HDL-C, Lp(a) levels and fasting
triglycerides and lowered HDL-C and ApoA1 levels. The analysis suggested a predictive
model showing that replacement of tFA with SFA, MUFA and PUFA decreases
TC/HDL-C ratio and total CHD risk with the greatest effects being with replacement by
PUFA [43].
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Background
In the presence of the experimental and observational data, adverse effects of
PHVO containing tFA on lipids and lipoprotein metabolism and its increased risk in the
progression of CHD in comparison to SFA is evident. Owing to the adverse health
implications of tFA, the Food and Drug Administration (FDA) proposed the labeling of
Trans Fats on the food label in 1999 and as of January 1, 2006, it is now mandatory to
include Trans Fat on the nutrition label [44, 45]. In the post-trans era, food industry is
looking for alternatives that can substitute PHVO in the food products with alternatives
that provide similar end products for the food industry without causing adverse health
effects. Alternatives that are being sort include using natural sources of saturated fat
(tropical oils), interesterified fats, genetically modifying oil seeds, modifying the process
of hydrogenation and blended oils.
Modification of the hydrogenation process
Modification of the hydrogenation process involves modifying the conditions
during hydrogenation like pressure, temperature and catalyst. Altering of the process
would affect the amount of tFA formed, melting point of the resulting fat and the solid fat
content. The process would decrease the amount of tFA formed and could also alter the
sensory properties of fried food and consumer acceptability in use in baked products
[34, 46].
Genetic modification of plant seeds
Genetic modification of plants to alter fatty acid composition can be attained by
traditional plant breeding or biotechnological methods. Genetic modification has been
attempted in case of high oleic sunflower and canola oils, mid oleic sunflower and
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soybean oils and low linolenic canola and soybean oils. The drawback to this method is
that it requires sustained efforts by the growers, need a long lead time of one to two
years and also incur more cost than traditional oils [34, 46].
Blending Oils
Blended oils are obtained by physically mixing two or more oils. Blends are
generally prepared by mixing partially hydrogenated, fully hydrogenated or tropical oil
with a liquid vegetable oil. This approach has been used for better thermal stability of
the oil. The physical properties of the native oils in the process remain intact, but the
blends may not yield the desired physiochemical and nutritional properties consistently.
This can be overcome by the process of interesterification [34, 46].
Interesterification (IE)
Interesterification or the process of randomization is an alternative to partial
hydrogenation and can generate fats with higher melting points. The process involves
fully hydrogenating an oil to make a fully saturated hard stock (either 16:0 or 18:0)
followed by randomization of fatty acids to achieve the degree of plasticity required. The
two main oils in terms of world supply are palm oil and soybean oil, which can be used
in the process of IE, yielding an 18:0:16:0 ratios of 85:15 for soybean oil and 55:45 for
palm oil [47]. Randomization can be achieved by
(a) Chemical Process: In chemical IE, an unhydrogenated liquid vegetable oil
(85%) is mixed and heated with a fully hydrogenated vegetable oil (15%) in the
presence of a chemical catalyst sodium methoxide [46] . The process causes a random
arrangement of fatty acids on all the three positions on the glycerol molecule and the
composition of the TAG being formed can be controlled to a certain extent by controlling
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the relative amounts of fat/oil used for the process [48]. One of the disadvantages of the
process is the substantial oil loss due to the formation of fatty acid methyl esters [48].
(b) Enzymatic randomization: A heat stable 1, 3 specific lipase is employed in the
enzyme based interesterification resulting in partially randomization instead of complete
randomization in case of the chemical process. Enzymatic IE is preferred over chemical
IE when a specific TAG is desired and does not lead to unwanted intermediates causing
wastage of oils. The drawbacks for this process include long reaction time, higher
sensitivity to reaction conditions and high cost.
The advantages of IE are that the process does not change the degree of
unsaturation of the fatty acids and maintains the orientation of the isomers in the cis
form [49]. The process imparts enhanced oxidative stability as achieved in PHVO [34].
The process leads to the formation of tFA but less than 10% as opposed to 30-50% in
PHVO [34, 46, 50].In the process the physical and nutritional properties of the oils may
change leading to altered absorption compared to native oils. The position of the fatty
acid on the glycerol molecule and which saturated fatty acid (16:0 or 18:0) should be
used in terms of health implications is one of the target areas of research. The
absorption and health implications of these interesterified oils are presently under
investigation and need to be understood in depth before it becomes the replacement for
PHVO [47].
In order to replace PHVO, various alternatives are being considered. The main
points of consideration in choosing the alternatives would be cost, availability, oxidative
stability, functionality in terms of appearances, texture and flavor and nutrient
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composition. Increased dietary fatty acid saturation is one of the inevitable requirements
to achieve some of the above targets.

Replacement of Saturated Fatty Acids with Carbohydrates
Limiting intake of SFA requires substitution of other nutrients for isocaloric
intakes, generally achieved with carbohydrates. Compared with CHO, SFA intakes raise
TC, LDL-C, but lowers TG and raises HDL-C [30]. In a randomized control study,
greater reductions in plasma SFA levels were seen in response to a CHO restricted diet
with 3 fold SFA compared to a low fat diet [51]. Knopp et al suggested a negating effect
of decreasing SFA with increased plasma concentration of palmitate with increase CHO
intake [52]. CHO restricted diet with high SFA compared with CHO restricted diet with
high unsaturated fatty acids showed no differences in the TC:HDL-C ratio [53]. In a
weight loss study with low CHO diets, LDL and TC:HDL-C ratios did not increase
despite high intakes of SFA [54]. Substitution of SFA for CHO increased HDL-C with no
net effect on TC:HDL-C ratio. PUFA and MUFA substitutions reduced TC:HDL-C ratio
compared with SFA. In regards to individual SFA, there is a smaller LDL-C and HDL-C
raising effect with substitution for CHO with SFA of increasing chain length with no net
effect on TC:HDL-C ratio [30]. Krauss et al studied the effects of moderate CHO
restriction on atherogenic dyslipidemia in conjunction with low or high SFA intake.
Results from the study revealed that in context of moderate CHO restriction (26%), high
SFA (15%) showed an increase in LDL-C compared with low SFA (7-9%) with the LDL
increase attributed to increase in mass of large LDL particles [55].
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Replacing CHO for SFA pose additional complications with little known about the
type of CHO needed for replacement. Effects of high CHO diets, coupled with
overweight or obesity caused worsening of atherogenic dyslipidemia. To fully elucidate
SFA replacement with CHO, its effects on cholesterol metabolism and regulation need
to be evaluated.

Cholesterol Regulation and Homeostasis
Cholesterol, found in the lipid bilayer of the cell membrane, is a steroid based
alcohol with both hydrophilic and hydrophobic properties. Being a structural component
of the plasma membrane, it provides stability, flexibility and permeability to the cell. It is
critical for cell viability, growth, regulation of integral protein function and transcriptional
regulation. It plays an essential role in synthesis of steroid hormones, bile acids and
provides function to fat soluble vitamins. Cholesterol can be synthesized endogenously
in the liver from Acetyl CoA and therefore is not an essential nutrient. In the body, lipid
components TG and cholesterol along with phospholipids and protein are packaged and
carried in the blood as lipoproteins [11, 56]. The density of the lipoprotein particle is
ascertained by the proportion of lipids and protein in the particle; higher the amount of
lipids, the less dense is the particle. Density of the lipoprotein particles changes
throughout the metabolic pathway. Lipoproteins interact with lipoprotein lipase which act
on the circulating particles releasing free fatty acids, thus making the lipoproteins
denser. The protein portion of the lipoprotein is called Apolipoprotein (Apo). They
provide stability and confer specificity on the lipoprotein complexes allowing them to be
recognized by specific receptors on the cell surface. Apo also stimulates certain
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enzymatic reactions which in turn regulate lipoprotein metabolic functions. The five main
lipoprotein classes are Chylomicrons (CM), Very low density lipoprotein (VLDL),
Intermediate density lipoprotein (IDL), Low density lipoprotein (LDL) and High density
lipoprotein (HDL).
The primary form of lipoproteins formed from dietary lipids is the CM. The role of
the CM is to deliver lipids to adipose and muscle tissues (80%) and to the liver (20%) in
the form of CM remnants. CM remnants are removed by the liver by endocytosis
following interaction of specific receptors for Apo E or B/E on the cell surface. VLDL
have a density of <1.006 g/mL and are synthesized in the liver. They provide the major
medium of transport of TG in the fasting state. As the VLDL circulates, lipoprotein lipase
cleaves TG giving rise to IDL which is rapidly converted to LDL.
LDL is the catabolic product of VLDL with density of 1.006-1.063 g/mL and can be
identified by the major protein Apo B-100, the major protein of LDL. LDL contains and
transport about 50-70% of total serum cholesterol to the liver and peripheral tissues by
interactions with LDL B-100 surface receptors. Once bound to the receptors, LDL is
internalized by endocytosis, dissociated in the lysosome into amino acids, free fatty
acids and free cholesterol (FC) [57]. FC exerts regulatory functions in the liver by
decreasing the activity of HMGCoA reductase, the rate limiting enzyme in the
endogenous synthesis of cholesterol and increasing the activity AcylCoA-cholesteryl
acyl transferase (ACAT), which converts FC to cholesterol esters (CE). Also, it lowers
the concentration of receptor mRNA, suppressing the synthesis of LDL receptors and
hence preventing entry of LDL into the cell [11, 57]. High concentrations of LDL in the
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plasma have been implicated in the progression of cardiovascular disease and therefore
considered the atherogenic lipoprotein.
HDL is the most dense lipoprotein with a density of 1.063<d<1.21 g/mL and can be
identified by their major protein ApoA1. HDL is synthesized in the liver and intestine is
considered the anti-atherogenic lipoprotein owing to its function of removing free
cholesterol from the cells and other lipoproteins and returning the cholesterol to the liver
for excretion in the bile.

Reverse Cholesterol Transport: Importance and Regulation
Cellular cholesterol efflux is a critical event for cholesterol homeostasis. In cells of the
peripheral tissues, excess cellular cholesterol needs to be removed and transported to
the liver for reutilization and excretion. This process is termed Reverse Cholesterol
Transport (RCT). HDL serves as the major acceptor for cellular cholesterol. A
membrane bound protein ATP-binding cassette (ABC) transporter mediates cholesterol
efflux. This process marks the rate limiting step in RCT. ABCA1 utilizes ATP to transfer
Phospholipids and cholesterol to the nascent HDL particle. Absence of ABCA1 is
associated with an autosomal recessive disorder, Tangier’s disease, leading to absence
of plasma HDL and HDL mediated efflux. ABCA1 gene mutations lead to low HDL and
high TG suggesting its role in the progression of CVD [58]. It is also suggested that
mutations in ABCA1 may be responsible for almost 10% cases of low HDL-C in
population based studies [59].
HDL is mediated through its Apo-A1 component, the main protein for HDL. ApoA1
is primarily synthesized in the liver and the intestine. Individuals with ApoA1 deficiency
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fail to form normal HDL particles. ApoA1 promotes cholesterol efflux and increased
ApoA1 expression leads to more cholesterol taken up for excretion. Mutations of ApoA1
have been seen, but one of the targeted mutations is the ApoA1Milano, which is
considered atheroprotective and has shown to reduce the size of atheroma in patients
with CHD [60]. Although the exact mechanisms are still being studied, it has the
potential of being considered as a therapeutic target in elevating the HDL-C levels [59].
ApoA1 stimulates the activity of the enzyme lecithin: cholesterol acyltransferase
(LCAT). This enzyme mediates the esterification of free cholesterol. Cholesteryl esters
resulting from this reaction can then exchange cholesterol esters for triglycerides readily
among plasma lipoproteins mediated by cholesterol ester transfer protein (CETP).
CETP activity poses an effect on ApoA and ApoB containing particles, HDL and VLDL
and LDL particles respectively. Studies suggest low prevalence of CHD among subjects
with CETP deficiency due to increased HDL-C [61]. Over expression of CETP leads to
increased VLDL and LDL levels which is pro-atherogenic [62]. The exact role of CETP
and whether decrease in CETP is cardio protective is still under scrutiny [59].
Cholesteryl esters can then be selectively taken up by the liver mediated by
SR-B1 or indirectly via LDL, following CETP transfer from HDL to LDL. This is mediated
by the affinity of the LDL receptors for ApoB and E [11, 63]. SR-B1 plays an important
role in the clearance as well as recycling of the HDL particles. Compared to complete
internalization of LDL particle, SR-B1 selectively binds to the HDL particle through the
ApoA1 component, sequesters cholesterol esters and takes them to the hepatocytes for
bile acid synthesis. In this way the HDL particle is quickly recycled and ready for more
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cholesterol efflux [62]. SR-B1 deficiency is associated with reduction in the clearance of
HDL-C from circulation.
Few studies have been done to understand the underlying mechanisms of effects
of dietary fat through hepatic gene expression. Dorfman et al revealed differential
effects of dietary fatty acids on expression of RCT genes in hamsters [64]. Hatahet et al
also studied the effects of dietary fat on LCAT, ApoA1 and SR-B1 in rats to explore their
potential role in the progression of atherosclerosis [65]. In transgenic mice models,
Azrolan et al showed that a diet high in SFA increased mRNA levels of hepatic ApoA1
[66]. More research is warranted to see the differential role of individual saturated fatty
acids and understanding the underlying mechanisms.
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Summary and Specific Aims
Consumption of Saturated fatty acids (SFA) and partially hydrogenated vegetable
oils (PHVO) containing trans-fatty acids (tFA) has been associated with higher
incidence of coronary heart disease (CHD). Experimental and observational data
suggests that consumption of SFA and PHVO containing tFA leads to increased total
cholesterol and LDL-cholesterol (LDL-C) but compared to SFA, tFA lowers HDLcholesterol (HDL-C) leading to an increased risk for CHD. The evidence has prompted
health agencies to advocate reduction or complete elimination of PHVO from the food
supply. In the post-trans era, alternatives to PHVO are being considered including
interesterified (IE) oils, genetically modified oils and blended oils providing increased
dietary fat saturation compared to naturally occurring vegetable oils. Since health
agencies are seeking alternatives to PHVO, our long term goal is to establish the effects
of these alternatives on plasma lipoprotein metabolism. The objective of this PhD
proposal is to evaluate the effects of dietary fat saturation on lipoprotein metabolism
using – High Linoleic soybean oil (Hi-LO), High Linoleic Low Linolenic Soybean Oil (HiLO Low-LN), High Stearic and Linoleic Soybean oil (Hi-SLO), High Oleic Oil Blend
(palm, corn & sunflower) (Hi-OL) and a palm oil fraction with an increased content of
oleic acid (Hi-PO). The central hypothesis for the present study is that dietary fat
saturation will not contribute to an adverse lipid profile. The rationale for the proposed
studies is that once the effects of dietary fat saturation on lipoprotein metabolism has
been established, it will allow for more rapid elimination of PHVO from the food supply.
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To test the above hypothesis, the specific aims of my dissertation research were
as follows:
Specific Aim 1: To evaluate the effects of naturally occurring, blended, interesterified
and genetically modified oils (with different fatty acid compositions) on lipid and
lipoprotein metabolism in Mongolian gerbil and Golden Syrian hamster.
Specific Aim 2: To document the extent to which the amount and type of Saturated
Fatty acids affect lipoproteins in Golden Syrian hamster.
Specific Aim 3: To examine postprandial changes in lipids following an oral challenge
to test oils with various fatty acid compositions in human subjects.
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Chapter 2: Materials and Methods
The first objective of the present study was to evaluate the effects of naturally
occurring, blended, interesterified and genetically modified oils (with different fatty acid
compositions) on lipid and lipoprotein metabolism. Two animal models were used;
gerbils - as they are highly sensitive to fatty acid manipulations and hamsters which are
widely accepted as appropriate models to depict human lipoprotein metabolism. By
employing both animal models, any effects on lipoprotein metabolism could be readily
determined.
Model 1: Gerbil
Male Mongolian Gerbils (8 weeks of age, initial weight 60 g) were obtained from
Charles River Laboratories (Wilmington, MA). A total of 96 gerbils (21 for Experiment 1
and 75 for Experiment 2) were obtained. Upon arrival, gerbils were housed in individual
cages in an isolation room with a 12-h light-dark cycle (lights on 6am, lights off 6pm)
and were fed a purified rodent diet (#5001, LabDiet), ad libitum, and allowed free
access to water. After a week of acclimatization, the gerbils were randomly assigned to
one of the feeding groups.
Experiment 1: CHOW (CHOW, n=3), Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL,
n=6) or Linoleic Acid supplemented diet using Soybean Oil (Hi-LO, n=6).
Experiment 2: CHOW (CHOW, n=4), Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL,
n=15), Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid
supplemented diet using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid
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and Linoleic Acid supplemented diet using Interesterified Soybean Oil (Hi-SLO, n=15).
Veggie Fruit Oil and Palm Olein were provided by the Nisshin Oillio Group Ltd (Japan),
Low Lin Soybean oil was a gift from Cargill (Minneapolis, MN), Coconut oil, and
soybean oil were provided by Dyets (Bethlehem, PA). The Interesterified fat was a gift
from Dr. Gerald McNeill, Loders Croklaan (Channahon, IL)
Diets were formulated based on current recommendations from the American
Society for Nutritional Studies and the nomenclature is based on the predominant and
relative fatty acid/s present in the diet. Gerbil diets were obtained in pelleted form from
Dyets Inc. (Bethlehem, PA). Sufficient diet was obtained for the entire duration of the
study. The diets were kept at -20°C, were removed weekl y as needed and refrigerated
at 4°C. The final diet (as fed to the animals) comprise d ~32% en from fat and each diet
was supplemented with 0.08% (w/w) cholesterol. For comparative purposes, a purified
rodent diet (CHOW) was also utilized. The diet compositions are summarized in Tables
2-1 and 2-3, with the final fatty acid composition listed in Tables 2-2 and 2-4. Final Fatty
acid (FA) compositions were calculated based on the FA compositions of the oils as
provided by the manufacturers.
A flowchart of the study design is shown in Figure 2-1. Briefly, the gerbils were
provided a fixed measured amount of diet (approximately 7g of diet per day) and had
free access to tap water. Food intake was monitored and was estimated by subtracting
the diet spilled in the cage from the amount of diet provided. Body weight was recorded
weekly to monitor their growth. All procedures and protocols were approved by the
Animal Investigation Committee of Wayne State University.
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Blood and Tissue Collection:
After 4 weeks of feeding the test diet, gerbils were fasted overnight and were
sacrificed while anaesthetized using 50% CO2:O2. .Blood was collected by cardiac
puncture into EDTA-containing tubes and was spun at 4500 rpm @ 4 degrees for 20
minutes. Sodium azide (10%), gentamycin sulphate (0.01%) and EDTA (10%) were
added to plasma samples and were stored at 40C. Liver was excised and wet weight
was recorded prior to flash freezing in liquid nitrogen. Adipose tissue was collected,
flash frozen in liquid nitrogen and stored at -80 degrees.

Lipoprotein Characterization:
Plasma lipoproteins were separated by density gradient, discontinuous
ultracentrifugation as described by Chapman et.al [67] with one modification, namely,
instead of 3 mL of plasma, 4 mL plasma was used. Plasma was pooled from 3-6 gerbils
from each group. The density of plasma was raised to 1.210g/mL by addition of solid
potassium bromide (0.325 g/mL plasma). Each discontinuous density gradient was then
constructed in 16X93 mm ultracentrifuge tubes (Beckman, Palo Alto, CA). 2mL of
sodium chloride-potassium bromide (NaCl-KBr) solution of density 1.240g/mL was
pipetted into the tube. The following solutions were then sequentially layered: 4 mL of
plasma at d = 1.21 g/mL, 2 mL of d = 1.063 g/mL, 2.5 mL of d = 1.019 g/mL and 3 mL of
d = 1.006 g/mL. Tubes were ultra-centrifuged in a Beckman SW-40.1 Ti rotor at
35000rpm, for 24 hours at 150C using Optima L-90K ultracentrifuge (Beckman Coulter,
Palo Alto, CA). After centrifugation, 25 fractions (500 µL each) were collected
sequentially from top into micro centrifuge tubes. For each fraction, total cholesterol and
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triglyceride were determined by enzymatic methods using kits purchased from Pointe
Scientific Inc. (Canton, MI).
For Experiment 2: In addition to total cholesterol and triglyceride, phospholipids
and protein in the fractions were analyzed using enzymatic kit from Wako Chemicals
USA (Richmond, VA) and Lowry Assay [68] respectively.

Determination of Liver lipids
Liver lipids were extracted using the Folch method [69]. Briefly, approximately
0.5g of liver samples was taken. Samples were homogenized in 10mL of chloroformmethanol solution 2:1 (v/v) and kept overnight at room temperature in a shaking water
bath. Phases were separated by the addition of 3mL 0.5% H2SO4. The upper phase
was removed and the lower phase was brought to a volume of 10mL. Aliquots of 50µL
were removed and dried overnight and reconstituted in 50µL of EtOH. Total cholesterol
and free cholesterol were determined using enzymatic kits from Pointe Scientific Inc.
(Canton, MI) and Wako Chemicals USA (Richmond, VA) respectively. The difference
between total and free cholesterol represent cholesterol esters.

Model 2: Hamster
76 male Golden Syrian Hamsters (6 weeks of age, Initial weight 90g) were
obtained from Charles River Laboratories (Wilmington, MA). On arrival, hamsters were
housed in individual cages in an isolation room with a12-h light-dark cycle (lights on
6am, lights off 6pm) and were fed purified rodent diet (#5001, LabDiet) ad libitum and
allowed free access to water. After a week of acclimatization, hamsters were randomly
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assigned to one of the feeding groups: Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL,
n=15), Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid
supplemented diet using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic
Acid supplemented diet using Soybean Oil (Hi-LO, n=15).For the study, Veggie Fruit Oil
and Palm oil were provided by the Nisshin Oillio Group Ltd (Japan), Low Lin Soybean
oil was a gift from Cargill (Minneapolis, MN), Coconut oil, flaxseed oil and soybean oil
were provided by Dyets (Bethlehem, PA).
Diets were formulated based on current recommendations from the American
Society for Nutritional Studies and the nomenclature is based on the predominant and
relative fatty acid/s present in the diet. The diet contained 30% en from fat and each
diet was supplemented with 0.1% cholesterol. Sufficient diet was obtained for the entire
duration of the study. The diets were kept at -20°C, w ere removed weekly as needed
and refrigerated at 4°C. The diet compositions are sum marized in Table 2-5 with the
final fatty acid composition listed in Tables 2-6.
A flowchart of the study design is shown in Figure 2-2. Briefly, the hamsters were
provided a fixed measured amount of diet (approximately 10g of diet per day) and had
free access to tap water. Food intake was monitored and was estimated by subtracting
the diet spilled in the cage from the amount of diet provided. Body weight was recorded
weekly to monitor their growth. All procedures and protocols were approved by the
Animal Investigation Committee of Wayne State University.
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Blood and Tissue Collection
After 4 weeks of feeding the test diet, 48 hamsters were fasted overnight and
were sacrificed while anaesthetized using 50% CO2:O2. .Blood was collected by cardiac
puncture into EDTA-containing tubes and was spun at 4500 rpm @ 4 degrees for 20
minutes. Sodium azide (10%), gentamycin sulphate (0.01%) and EDTA (10%) were
added to plasma samples and were stored at 40C. Liver was excised and wet weight
was recorded prior to flash freezing in liquid nitrogen. Adipose tissue was collected,
flash frozen in liquid nitrogen and stored at -80 degrees.

The second objective of the study was to examine the extent to which the
amount and type of Saturated Fatty acids affect lipoproteins. Since hamsters are shown
to depict human lipoprotein metabolism, they were chosen as the model of evaluation
for the study.
Diets were formulated such that percentage of calories from protein,
monounsaturated fatty acids and polyunsaturated fatty acids were kept constant while
calories from fat were replaced with calories from carbohydrate. The diet compositions
are summarized in Table 2-7, with the final fatty acid composition listed in Table 2-8.
The diets were obtained in pelleted form from Dyets Inc. (Bethlehem, PA). Sufficient diet
was obtained for the entire duration of the study. The diets were kept at -20°C, were
removed weekly as needed and refrigerated at 4°C.
90 male Golden Syrian Hamsters (6 weeks of age, Initial weight 90g) were
obtained from Charles River Laboratories (Wilmington, MA). On arrival, hamsters were
housed in individual cages in an isolation room with a 12-h light-dark cycle (lights on
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6am, lights off 6pm) and were fed purified rodent diet (#5001, LabDiet) ad libitum and
allowed free access to water. After a week of acclimatization, hamsters were randomly
assigned to one of the six feeding groups: Lauric and Myristic Acid supplemented diet
with varying percentage of fat; 60%LM, n=15; 45%LM, n=15; 30%LM, n=15; 21%CON,
n=15; and Palmitic Acid supplemented group with varying percentages of fat; 30%PA,
n=15; 45%PA, n=15. The nomenclature is based on the percentage of fat present in the
diet along with the predominant saturated fatty acid/s. For the study, Palm oil was
provided by the Nisshin Oillio Group Ltd (Japan) and Loders Croklaan (Channahon, IL);
Coconut oil was provided by Dyets (Bethlehem, PA).
A flowchart of the study design is shown in Figure 2-3. Briefly, the hamsters were
provided a fixed measured amount of diet (approximately 9g of diet per day) and had
free access to tap water. Food intake was monitored and was estimated by subtracting
the diet spilled in the cage from the amount of diet provided. Body weight was recorded
weekly to monitor their growth. All procedures and protocols were approved by the
Animal Investigation Committee of Wayne State University.

Blood and Tissue Collection
After 7 weeks of feeding the test diet, 48 hamsters were fasted overnight and
were sacrificed while anaesthetized using 50% CO2:O2. .Blood was collected by cardiac
puncture into EDTA-containing tubes and was spun at 4500 rpm @ 4 degrees for 20
minutes. Sodium azide (10%), gentamycin sulphate (0.01%) and EDTA (10%) were
added to plasma samples and were stored at 40C. Liver was excised and wet weight
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was recorded prior to flash freezing in liquid nitrogen. Adipose tissue was collected,
flash frozen in liquid nitrogen and stored at -80 degrees.

For hamsters from Specific Aim 1 and 2, common procedures are detailed below:

Plasma Lipid and Lipoprotein Characterization
Plasma was isolated from fresh blood samples and assayed for Total Cholesterol,
HDL-C and Triglycerides using enzymatic kits purchased from Pointe Scientific Inc.
(Canton, MI). The plasma lipoproteins were separated by sequential ultracentrifugation.
Three lipoprotein fractions were isolated based on human plasma density cuts for
lipoproteins, namely, VLDL/IDL (1.006-1.019 g/mL), LDL (1.019-1.055 g/mL) and HDL
(1.055-1.21 g/mL). For each fraction, total cholesterol and triglyceride were determined
by enzymatic methods using kits purchased from Pointe Scientific Inc. (Canton, MI).
Phospholipids and Free Cholesterol in the fractions were analyzed using enzymatic kit
from Wako Chemicals USA (Richmond, VA). Proteins in the fractions were analyzed
using Lowry Assay[68]. Cholesterol esters were calculated as a difference between
Total Cholesterol and Free Cholesterol. Particle size was determined using Van Heek
and Zilversmit [70]core to surface volume ratio, according to the formula [71]:
1.093(TG) + 1.044 (CE)
R= (nm) = ------------------------------------------------------- X (3*2.15)
0.968 (FC) + 0.97 (PL) + 0.705 (PR)

D (nm) = 2R + 2(2.15)
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Determination of Liver lipids
Liver lipids were extracted using the Folch method [69] as detailed for gerbils.

RNA Isolation
Liver sample (0.25-0.30 mg) was excised and was homogenized using polytron
homogenizer. Total RNA was isolated from the liver of the hamster using the RNeasy
Mini Kit (Qiagen, Valencia, CA) per the manufacturer's protocol. Following isolation,
RNA was quantified using a NanoDrop spectrophotometer and samples with a RNA
concentration greater than 350ng/ul were used for analysis. Denaturing Agarose gel
electrophoresis was performed to check for RNA quality. RNA samples were stored at 80°C until further analysis.
cDNA was synthesized from 1 µg of RNA using random primers (ImProm-II™
reverse transcriptase system, Promega, Madison, WI) and purified with the QIAquick
PCR Purification kit (Qiagen). The levels of cDNAs were quantified using a LightCycler
real time PCR machine (Stratagene, La Jolla, CA). For the analysis, all cDNA samples
were standardized to a concentration of 50ng/ul to ensure equal starting concentrations
for every sample. Triplicates for each sample were analyzed. PCR contained 3 µL of
purified cDNA, 12.5 µL of PCR master mix (SYBR Green, Applied Biosystems), and 0.5
µmol/liter each of forward and reverse primers (Invitrogen). The primer sequences for
ABCA1, ApoA1, CETP, SR-B1 and GAPDH used are summarized in Table 2-9. No
template controls were present on each plate to ensure no contamination of primers,
reagent or nuclease free water and to check for primer dimers. For all amplifications,
PCR conditions consisted of an initial denaturing step of 95 °C for 10 min followed by 40
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cycles of 95 °C for 30 s, 58 °C for 30 s and 72 °C for 2 s with a melting curve analysis
from 58 to 95 °C to confirm specificity. The level of each transcript was normalized to
GAPDH. Results are expressed as mean values from 4-5 animals per experimental
group.

PCR Result Analysis
Ct values were normalized using GAPDH as an endogenous control. Relative
gene expression was calculated using the equation
2ˆ (- (avg. (Ct gene of interest) - avg. (Ct Housekeeping gene)))
The relative expression values were used to determine fold changes in the test diet
compared to the control diet.

Human postprandial study
The postprandial state is a reflection of the metabolic state in humans due to
regular diet intake. The third objective of the study was to evaluate postprandial
changes in lipids following an oral challenge to test oils with various fatty acid
compositions.
Subjects were administered a test “smoothie” prepared by blending 240g nonfat milk, 140g frozen strawberries, ~55g banana, 24g sugar and 60g test oil (Hi-OL,
Hi-PO or Hi-LO). The “smoothie” provided 820kcal with 66% en from fat, 30% en
from carbohydrates and 5% en from protein. This test meal represented an extreme
dietary oral fat challenge.
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A flowchart of the study design is shown in Figure 2-4. Briefly, 9 subjects, aged
between 18 and 50 years, generally healthy were recruited for the study. Subjects
who volunteered for the study filled out a basic questionnaire for any known
preexisting conditions of high BP, TC, TG, diabetes or heart problems. As a
prescreen test, fasting blood samples for the subjects were taken and plasma was
analyzed for TC, HDL-C and TG using enzymatic kits. Subjects were tested with
each of the 3 fat compositions namely Oleic Acid supplemented test oil using Veggie
fruit oil (Hi-OL), Palmitic and Oleic Acid supplemented test oil using Palm Olein (HiPO) or Linoleic acid supplemented test oil using Soybean oil (Hi-LO) with a wash out
period of 2 weeks. The nomenclature is based on the predominant and relative fatty
acid/s present in the diet. For the study, Palm oil and Veggie Fruit oil were provided
by the Nisshin Oillio Group Ltd (Japan) and Soybean Oil (Brand - Pure Wesson) was
purchased from local supermarket. All procedures and protocols were approved by
the Human Investigation Committee of Wayne State University.
The first time the subjects participated, they were asked to record their food and
beverage intake on the day before the experiment. Subjects reported fasting for 12
hours on the day of the study. They provided a fasting blood sample. They were then
administered the test meal smoothie which was consumed within 15 minutes. Additional
blood samples were collected at 2, 4 and 8 hours. All blood samples were collected by a
trained phlebotomist by venipuncture. On the day of the study, subjects were asked to
refrain from any rigorous physical activity and food. They were allowed approximately
300 mL of water or decaffeinated coffee without milk and sugar. On subsequent
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occasions subjects were asked to follow the diet they had consumed the evening before
the day of the experiment.

Blood Collection:
Blood was collected into EDTA-containing tubes at 0, 2, 4 and 8 hours and was
spun at 4500 rpm @ 4 degrees for 20 minutes. Sodium azide (10%), gentamycin
sulphate (0.01%) and EDTA (10%) were added to plasma samples which were kept at
40C.

Plasma Lipid and Lipoprotein Characterization
Plasma was assayed for Total Cholesterol, HDL-C and Triglycerides using
enzymatic kits purchased from Pointe Scientific Inc. (Canton, MI). To fully
characterize postprandial effects on lipoproteins induced by dietary fat blends, TAG
rich fractions (Sf>400, Sf 60-400, Sf 20-60) were isolated from all plasma samples
that were obtained at 0, 2, 4 and 8 hours using discontinuous ultracentrifugation [72].
Briefly, plasma was adjusted to d=1.1 g/mL. Four mL of this plasma was then
successively over layered with 3 mL solutions of density 1.063 g/mL, 1.02 g/mL and
1.006 g/mL. Following ultracentrifugation in a Optima L-90K ultracentrifuge (Beckman
Coulter, Palo Alto, CA) for 32 minutes at 15oC using a SW-40 Ti rotor, the Sf>400
fraction was obtained from the top 1mL of the gradient. The centrifuge tube was then
refilled with 1 mL of d 1.006 g/mL solution, and the tube was recentrifuged for 3 h 28
min to obtain the Sf 60-400 fraction recovered from the top 1mL. The ultracentrifuge
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tube was then refilled and a further 16 h ultracentrifugation yielded the Sf 20-60
fraction [72]. Triglycerides were measured in the TAG rich fractions using an
enzymatic kit purchased from Pointe Scientific Inc. (Canton, MI).

CETP activity
CETP is active during triglyceridemic state. CETP activity was measured in
plasma samples using CETP Activity Assay kit purchased from BioVision (Mountain
View, CA). CETP activity was measured at excitation 465nm and emission of 535nm
using microplate reader (Tecan GENios Plus). The activity was observed as an
increase in florescence intensity and was expressed as pmol/ul plasma/hr.

Statistical Analysis
All statistical analyses were performed using PASW Statistics 18 for
Windows® (SPSS Inc. Chicago, IL). Data were analyzed using one-way ANOVA
followed using Tukey post-hoc tests. Results are presented as the mean ± SD and
significance was considered at p≤ 0.05.
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TABLE 2-1. Specific Aim 1: Experiment 1: Composition of purified diets for
gerbils (g/kg).
___________________________________________________________________
Ingredient
Hi-LM
Hi-OLa
Hi-LO
___________________________________________________________________
Vitamin Free Casein
105
105
105
Lactalbumin
105
105
105
Dextrose
180
180
180
Cornstarch
250.17
250.17
250.17
Dyetrose
100
100
100
Cellulose
59.5
59.5
59.5
FAT
144
144
144
Coconut Oil
Veggie Fruit Oil
Soybean Oil

142.6
0
1.4

0
144
0

0
0
144

TBHQ
0.029
0.029
0.029
Mineral mix #290003
40
40
40
Vitamin mix #390005
10
10
10
DL-Methionine
3
3
3
Choline Bitartrate
2.5
2.5
2.50
Cholesterol
0.8
0.8
0.8
Caloric content (kcal/kg diet)
Protein
800 (19.6%)b 800 (19.6%)
800 (19.6%)
Carbohydrate
1936 (47.5%) 1936 (47.5%)
1936 (47.5%)
Fat
1296 (31.8%) 1296 (31.8%)
1296 (31.8%)
___________________________________________________________________
Diets were prepared and pelleted by Dyets Inc. (Bethlehem, PA).
a Veggie Fruit Oil was supplied by Nisshin Oillio Group Ltd., Tokyo, Japan.
b Percent of total calories contributed by each macronutrient.
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TABLE 2-2. Specific Aim 1: Experiment 1:Percentage of total dietary calories
contributed by each fatty acid.
____________________________________________________________________
Fatty acid
Hi-LM
Hi-OL
Hi-LO
____________________________________________________________________
% of total calories
12:0
15.5
0.06
0
14:0
7.08
0.13
0
16:0
3.05
5.47
3.18
18:0
0.71
0.80
1.27
18:1
2.44
14.9
7.95
18:2
0.86
9.01
16.54
18:3
0.02
1.06
2.23
____________________________________________________________________
∑ SFAs
28.47
6.47
4.45
∑ MUFAs
2.44
14.9
7.95
∑ PUFAs
0.88
10.07
18.77
P/S ratio
0.031
1.56
4.22
____________________________________________________________________
Major FA indicated in bold-face. Fatty Acid composition was calculated based on the FA profile
supplied by Nisshin Oillio and Dyets Inc.
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TABLE 2-3. Specific Aim 1: Experiment 2: Composition of purified diets for
gerbils (g/kg).
________________________________________________________________________
Parameter
-----------------------------------Diet----------------------------------------Hi-LM
Hi-SLO
Hi-LO Low-LN Hi-PO
Hi-OL
________________________________________________________________________
Vitamin Free Casein
Lactalbumin
Dextrose
Cornstarch
Dyetrose
Cellulose
FAT
Coconut Oil
Interesterified Fat
Low Lin Soybean Oil
Palm Olein IV67
Soybean Oil
Veggie Fruit Oil
TBHQ
Mineral Mix #290003
Vitamin Mix # 390005
DL-Methionine
Choline Bitratrate
Cholesterol

105
105
180
250.17
100
59.5
144

105
105
180
250.17
100
59.5
144

105
105
180
250.17
100
59.5
144

105
105
180
250.17
100
59.5
144

105
105
180
250.17
100
59.5
144

142.6
0
0
0
1.4
0

0
144
0
0
0
0

0
0
144
0
0
0

0
0
0
144
0
0

0
0
0
0
0
144

0.029
40
10
3
2.5
0.8

0.029
40
10
3
2.5
0.8

0.029
40
10
3
2.5
0.8

0.029
40
10
3
2.5
0.8

0.029
40
10
3
2.5
0.8

_______________________________________________________________________
Caloric content (kcal/kg diet)
Protein
------------------------------ 800 (19.6%)b ----------------------------Carbohydrate
------------------------------1936 (47.5%) -----------------------------Fat
------------------------------1296 (31.8%) -----------------------------________________________________________________________________________
Diets were prepared and pelleted by Dyets Inc. (Bethlehem, PA). Palm Olein IV67 and Veggie Fruit Oil
was supplied by Nisshin Oillio Group Ltd., Tokyo, Japan. Low linoleic soybean oil was from Cargill, Inc.
The Interesterified fat was a gift from Loders Croklaan
b Percent of total calories contributed by each macronutrient.
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TABLE 2-4. Specific Aim 1: Experiment 2: Percentage of total dietary calories contributed
by each fatty acid.
________________________________________________________________________
Fatty Acid
-----------------------------------Diet----------------------------------------Hi-LM
Hi-SLO
Hi-LO Low-LN Hi-PO
Hi-OL
________________________________________________________________________
---------------------------% of total calories -----------------------------12:0
14:0
16:0
18:0
18:1
18:2
18:3

15.49
7.08
3.05
0.71
2.44
0.86
0.02

0
0.04
3.84
8.49
5.24
12.02
1.65

0
0.03
3.43
1.34
7.57
18.09
1.02

0.12
0.34
9.72
1.07
14.92
4.43
0.98

0.06
0.13
5.47
0.80
14.87
9.01
1.06

________________________________________________________________________
∑ SFA
∑ MUFA
∑ PUFA

28.47
2.44
0.88

12.38
5.24
13.67

4.80
7.57
19.11

11.25
14.92
5.41

6.47
14.87
10.07

P/S ratio
0.03
1.10
3.98
0.48
1.56
________________________________________________________________________
Major FA indicated in bold-face. Fatty Acid composition was calculated based on the FA profile supplied
by Nisshin Oillio, Cargill Inc., Loders Croklaan and Dyets Inc.
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TABLE 2-5. Specific Aim 1: Experiment 3: Composition of purified diets for
hamsters(g/kg).
_____________________________________________________________________
Ingredient
High LM Hi-LO High PO High LO High OL
Low-LN
_____________________________________________________________________
Casein
110
110
110
110
110
Lactalbumin
110
110
110
110
110
L-arginine
2.5
2.5
2.5
2.5
2.5
L-tryptophan
0.3
0.3
0.3
0.3
0.3
Cornstarch
370.2
370.2
370.2
370.2
370.2
Dyetrose
175
175
175
175
175
Cellulose
44
44
44
44
44
FAT
144
144
144
144
144
Coconut Oil
Flax Oil
Low Lin soybean oil
Palm Olein (IV68)a
Soybean Oil
Veggie Fruit Oila

142.56
0
0
0
1.44
0

0
0
144
0
0
0

0
7.2
0
136.8
0
0

0
0
0
0
144
0

0
0
0
0
0
144

Mineral mix #260001
35
35
35
35
35
Vitamin mix #360001
10
10
10
10
10
Choline Bitartrate
2
2
2
2
2
Cholesterol
1
1
1
1
1
Caloric content (kcal/kg diet)
Protein
---------------------------834 (20.1%)b ----------------Carbohydrate
--------------------------1998 (48.1%) ------------------Fat
--------------------------1260 (30.4%) ------------------_____________________________________________________________________
Diets were prepared and pelleted by Dyets Inc. (Bethlehem, PA).
aPalm Olein (IV68) and Veggie Fruit Oil were supplied by Nisshin Oillio Group Ltd., Tokyo, Japan. Low
linolenic soybean oil was from Cargill, Inc.
bPercent of total calories contributed by each macronutrient.
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TABLE 2-6. Specific Aim 1: Experiment 3: Percentage of total dietary calories
contributed by each fatty acid.
_____________________________________________________________________
Fatty Acid
High LM Hi-LO High PO High LO High OL
Low-LN
_____________________________________________________________________
% of total calories
12:0
14.81
0
0.12
0
0.06
14:0
6.78
0.03
0.32
0
0.12
16:0
2.92
3.28
9.29
3.04
5.23
18:0
0.67
1.28
1.02
1.22
0.77
18:1
2.33
7.24
14.26
7.6
14.22
18:2
0.82
17.3
4.24
15.81
8.62
18:3
0.02
0.97
0.94
2.13
1.02
_____________________________________________________________________
∑SFAs
25.18
4.59
10.75
4.26
6.18
∑MUFAs
2.33
7.2
14.26
7.6
14.2
∑PUFAs
0.84
18.27
5.18
17.94
9.64
P/S ratio
0.03
3.98
0.48
4.21
1.56
_____________________________________________________________________
Major FA indicated in bold-face. Fatty Acid composition was calculated based on the FA profile
supplied by Nisshin Oillio, Cargill Inc., and Dyets Inc.
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TABLE 2-7. Specific Aim 2: Composition of purified diets for hamsters (g/kg).

Ingredients

60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

Caesin

554.9

519.1

465.4

436.8

465.4

519.1

Lactalbumin

604.5

565.5

507

475.8

507

565.5

L-Arginine

10

10

10

10

10

10

L-Tryptophan

1.2

1.2

1.2

1.2

1.2

1.2

Total

1170.6

1095.8

983.6

923.8

983.6

1095.8

Pro %

23.6

23.9

23.9

23.9

23.9

23.9

Cornstarch

453

666

1225

1347

1225

666

Dyetrose

317

707

631

745

631

707

Total

770

1373

1856

2092

1856

1373

CHO %

15.5

29.9

45.1

54.0

45.1

29.9

Safflower

505

476

419

410

0

145

Sunflower

327

373

407

410

0

0

Coconut

2138

1221

407

0

0

269

Corn

0

0

0

0

555

414

Palm Olien

0

0

0

0

678

0

Palm Stearin

0

0

0

0

0

1242

Total (kcal)

2970

2070

1233

820

1233

2070

Fat %

59.9

45.1

30.0

21.2

30.0

45.1

Cholesterol

1.2

1.1

1.0

0.94

1.0

1.1

2

2

2

2

2

2

Choline

Diets were prepared and pelleted by Dyets Inc. (Bethlehem, PA).
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TABLE 2-8. Specific Aim 2: Percentage of total dietary calories contributed by each
nutrient.

60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

SFA %

40.62

25.73

10.83

1.97

10.12

24.56

CHO %

15.5

29.9

45.1

54

45.1

29.9

MUFA %

9.83

9.81

10.01

9.79

9.86

10.44

PUFA %

9.5

9.39

9.06

9.14

9.87

10

PRO %

23.9

23.9

23.9

23.9

23.9

23.9

P/S ratio

0.23

0.36

0.84

4.64

0.98

0.41

____________________________________________________________________
Fatty Acid composition was calculated based on the FA profile supplied by Nisshin Oillio and Dyets Inc.
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TABLE 2-9. Reverse Cholesterol Transport Gene Primers
GENE
[73]

ABCA1
[74]
ApoA1
[75]
CETP
[74]
SR-B1
a
GAPDH

FORWARD

REVERSE

5’-ATAGCAGGCTCCAACCCTGAC-3’
5’-ACCGTTCAGGATGAAAACTGTAG-3’
5’-AAGGGTGTCGTGGTCAGTTCT-3’
5’-AAGCCTGCAGGTCTATGAAGC-3’
5’-ACCCAGAAGACTGTGGATGG-3’

5’-GGTACTGAAGCATGTTTCGATGTT-3’
5’-GTGACTCAGGAGTTCTGGGATAAC-3’
5’-ACTGATGATCTCGGGGTTGAT-3’
5’-AGAAACCTTCATTGGGTGGGTA-3’
5’-CAGTGAGCTTCCCGTTCAG-3’

All primers were provided by Invitrogen. Superscript numbers are the references from which the primers
were taken.
a
The primer sequence was a generous gift from Dr. Fazlul Sarkar and Dr. Smiti Gupta (Wayne State University).
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Figure 2.1: Specific Aim 1: Flowchart of Study Design for Gerbils (Experiment 1 and
Experiment 2)

96 Mongolian Gerbils
EXPERIMENT 1

EXPERIMENT 2

21 Gerbils
1 week acclimatization
CHOW (n=3), Hi-LM (n=6), Hi-OL (n=6), HiLO (n=6)

75 Gerbils
1 week acclimatization
CHOW (n=4), Hi-LM (n=13),
Hi-OL (n=15), Hi-SLO (n=15), Hi-LO LowLN (n=13), Hi-PO (n=14)

•
•

Body weight was taken weekly
Diet consumed was monitored for each gerbil

•
•

Sacrificed after 4 weeks on diet
Blood, Liver and Adipose Collected

•

Plasma
Lipids :Total Cholesterol (TC),HDL-Cholesterol (HDL-C) and Triglycerides (TG) were
assayed
Lipoprotein Isolation using Discontinuous U/C

•
•
•

Liver
Lipids Extracted: Folch Extraction;
Total Cholesterol (TC) and Free Cholesterol (FC) were assayed
Cholesterol Esters = TC - FC

•
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Figure 2.2: Specific Aim 1: Flowchart of Study Design for Hamsters

76 Golden Syrian Hamsters

•
•

1 week acclimatization
Hi-LM (n=16), Hi-OL (n=15), Hi-LO (n=15), Hi-LO Low-LN(n=15), Hi-PO (n=15)

•
•

Body weight was taken weekly
Diet consumed was monitored for each hamster

•
•

Sacrificed after 4 weeks on diet
Blood, Liver and Adipose Collected

•
•
•

Lipids :Total Cholesterol (TC),HDL-Cholesterol (HDL-C) and triglycerides (TG) were
assayed
Lipoprotein Isolation using Sequential Ultracentrifugation
Particle Diameter were determined

•
•
•
•

Lipids Extracted: Folch Extraction;
Total Cholesterol and Free Cholesterol assayed
Cholesterol Esters = TC – FC
RNA isolation, RT-PCR for Reverse Cholesterol Transport genes

Plasma

Liver

•
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Figure 2.3: Specific Aim 2: Flowchart of Study Design for Hamsters

90 Golden Syrian Hamsters

•
•

•
•
•

•
•

1 week acclimatization
60%LM (n=15), 45%LM (n=15),
30%LM (n=15), 21%CON
(n=15), 30%PA (n=15), 45%PA
(n=15)

•
•

Body weight was taken weekly
Diet consumed was monitored
for each hamster

48 hamsters sacrificed after 7
weeks on diet
Blood, Liver and Adipose
Collected

Plasma
Lipids :Total Cholesterol (TC),HDL-Cholesterol
(HDL-C) and triglycerides (TG) were assayed
Lipoprotein Isolation using Sequential
Ultracentrifugation
Particle Diameter were determined

Liver
•
•
•
•

Lipids Extracted: Folch Extraction;
Total Cholesterol and Free Cholesterol assayed
Cholesterol Esters = TC – FC
RNA isolation, RT-PCR for Reverse Cholesterol
Transport genes

42 Hamsters
Weight Loss Study
(not reported in this thesis)
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Figure 2.4: Specific Aim 3: Flowchart of Study Design for Postprandial Human Study.

• 9 subjects
• (Age:18
(Age:18-55yrs)
• Generally healthy

12 hours fasting
before the day of
the study

Blood drawn @
2,4 and 8 hours

• Blood draw – fasting sample
• ORAL FAT CHALLENGE: (Smoothie: 820kcal 66%fat : 30% CHO: 5% PRO
Fat : Hi
Hi-PO, Hi-LO, Hi-OL
OL )on 3 separate days with 2 weeks wash out
period

• Plasma Lipid analysis (TC,TG and HDL
HDL-C)
Plasma Lipoprotein analysis (Discontinuous Ultracentrifugation)
CETP activity estimation
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Chapter 3: Results
Specific Aim 1
The first objective of the present study was to evaluate the effects of naturally
occurring, blended, interesterified and genetically modified oils (with different fatty acid
compositions) on lipid and lipoprotein metabolism in two different animal models.
Gerbils (Experiment 1 and 2) were used as they are highly sensitive to fatty acid
manipulations and Hamsters (Experiment 3) are widely accepted as appropriate models
for human lipoprotein metabolism. By employing both animal models, any alterations in
lipoprotein metabolism attributed to the dietary fats can be readily determined.

Diet Consumed
Gerbils and hamsters were fed purified pelleted diets. Food intake was monitored
every two to three days and was estimated by subtracting the diet spilled in the cage
from the amount of diet provided.
Experiment 1- Pilot Gerbil Study
The gerbils were randomly assigned to one of the feeding groups - CHOW
(CHOW, n=3), Lauric and Myristic Acid supplemented diet using Coconut oil (Hi-LM,
n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or a Linoleic
Acid supplemented diet using Soybean Oil (Hi-LO, n=6). Over the four week feeding
period, there were no significant differences in food intakes between the diet groups
(Table 3-1).
Experiment 2- Gerbil Study
The gerbils were randomly assigned to one of the feeding groups - CHOW
(CHOW, n=4), Lauric and Myristic Acid supplemented diet using Coconut oil (Hi-LM,
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n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic Acid
supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet
using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid
supplemented diet using Interesterified Soybean Oil (Hi-SLO, n=15). Over the four week
feeding period, there were no significant differences in food intakes between the diet
groups (Table 3-2).
Experiment 3- Hamster Study
The hamsters were randomly assigned to one of the feeding groups - Lauric and
Myristic Acid supplemented diet using Coconut oil (Hi-LM, n=15), Oleic Acid
supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic Acid supplemented
diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low
Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using
Soybean Oil (Hi-LO, n=15). Over the feeding period, there were no significant
differences observed in food intakes between the diet groups (Table 3-3).

Body Weight and Liver Weight
During the four week feeding period, there was a progressive increase in body
weight with age in gerbils and hamsters for all diet groups indicating adequacy of the
diets.
Experiment 1- Pilot Gerbil Study
There were no significant differences observed for change in body weight and
liver weight between the diet groups after the four week feeding period of the study.
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Liver weight taken as a percentage of body weight was not significantly different
between the diet groups (Table 3-1).
Experiment 2- Gerbil Study
There were no significant differences observed for change in body weight and
liver weight between the diet groups after the four week feeding period of the study.
When liver weight was taken as a percentage of body weight, the ratio of liver to body
weight was significantly lower in the Hi-SLO and Hi-LO Low-LN group compared with
Hi-LM and Hi-OL groups (Table 3-2).
Experiment 3- Hamster Study
There were no significant differences in the growth of the hamsters over the 4
week feeding period between the diet groups (Figure 3-1). No significant differences
were observed for change in body weight, liver weight and liver weight to body weight
between the five diet groups over the 4 weeks of the feeding period (Table 3-3).

Plasma Total Cholesterol, HDL-Cholesterol and Triglycerides
Experiment 1- Pilot Gerbil Study
Analyses of plasma revealed that the mean plasma TC was significantly lower
for Hi-OL and Hi-LO diet groups compared to Hi-LM (p ≤ 0.05). Also, mean plasma
HDL-C was significantly lower for Hi-OL and Hi-LO diet groups compared to Hi-LM (p
≤ 0.05) (Figure 3-2). Lauric acid has the greatest Total cholesterol raising effect and
also raises HDL-C most significantly compared to other fatty acids [30, 76]. This is
more pronounced in the gerbil model as in gerbils about 70% of TC is transported in
HDL [71, 77]. Based on the changes in TC and HDL-C, the TC:HDL-C ratio was
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significantly lower in Hi-LM diet groups compared with Hi-OL and Hi-LO groups (p ≤
0.05) (Figure 3-3).
Mean plasma triglycerides were significantly higher in the Hi-LM diet group
compared with Hi-OL and Hi-LO groups (p ≤ 0.05) (Figure 3-4). This is in agreement
with the effect seen with feeding high Lauric and Myristic acid diet in a gerbil model
compared to diet high in PUFA[71].
Experiment 2- Gerbil Study
Analyses of plasma revealed that the mean plasma TC was significantly lower
for all diet groups compared to Hi-LM (p≤0.05). Also, mean plasma HDL-C was
significantly lower for all diet groups compared to Hi-LM (p≤0.05) (Figure 3-5). As
mentioned earlier, lauric acid has the greatest total cholesterol raising effect and also
raises HDL-C most significantly [30, 76]. Since the increase in TC was proportional to
the increase in HDL-C for Hi-LM, the TC:HDL-C ratio was not significantly different
between the diet groups (Figure 3-6).
Mean plasma triglycerides were significantly higher in the Hi-LM diet group
compared with Hi-OL and Hi-PO groups (p≤0.05) (Figure 3-7).
Experiment 3- Hamster Study
Analyses of plasma revealed that the mean plasma TC was significantly lower
for all diet groups compared to Hi-LM and Hi-LO diets (p ≤ 0.05). Also, mean plasma
HDL-C was significantly lower for Hi-OL and Hi-PO diet groups compared to Hi-LM
and Hi-LO diet groups (p ≤ 0.05) (Figure 3-8). Since the increase in TC was
proportional to the increase in HDL-C, the TC:HDL-C ratio was not significantly
different between the diet groups (Figure 3-9).
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Mean plasma triglycerides (Figure 3-10) were not significantly different
between the diet groups.

Lipoprotein Fractions Analyses
Experiment 2- Gerbil Study
Fractions were designated based on plasma density cuts for gerbils; fractions 1-3
(d<1.018g/mL) are denoted as “VLDL”, fractions 4-8 (1.018<d<1.063 g/mL) are denoted
as “LDL” and fractions 9-15 (d>1.063g/mL) are denoted as “HDL” (Figure 3-11).
In the VLDL fraction, there were no significant differences observed for total
cholesterol, phospholipids and protein. For triglycerides in the VLDL fraction, Hi-LM
showed the maximum increase compared to all other diet groups although it did not
reach significance (p=0.16) (Figure 3-12A). In the LDL fraction, total cholesterol and
phospholipids were lower in all diet groups compared with Hi-LM. Also, protein for diets
Hi-PO and Hi-OL were significantly lower compared with Hi-LM (Figure 3-12B).

In the

HDL fraction, total cholesterol, phospholipids and protein was lower in all diet groups
compared with Hi-LM (Figure 3-12C). The analyses of the lipoproteins is in consensus
with the results seen in plasma, where the triglycerides were higher in the Hi-LM group
compared to other diet groups as VLDL is the major carrier of triglycerides. Also, In the
LDL and HDL fractions total cholesterol was highest in the Hi-LM group compared to all
other diet groups as seen in plasma analyses.
Experiment 3- Hamster Study
CETP transfers cholesterol esters from HDL to VLDL and LDL in exchange for
triglycerides. Hamsters show CETP activity similar in humans and therefore can help in
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better understanding of the changes for the LDL and HDL fractions in TG and CE. To
fully elucidate the changes, plasma lipoproteins were separated using sequential
ultracentrifugation. Three lipoprotein fractions were isolated using density cuts of
lipoproteins for humans, namely, VLDL/IDL (1.006-1.019 g/mL), LDL (1.019-1.055
g/mL) and HDL (1.055-1.21 g/mL). For each fraction, total cholesterol, triglycerides, free
cholesterol, phospholipids and protein were determined. Cholesterol esters were
computed as a difference in total and free cholesterol.
In the VLDL fraction, there were no significant differences observed in the
composition of the particle between the diet groups. In the LDL fraction, triglycerides
were higher in the Hi-LM and Hi-PO diet groups compared with Hi-LO and Hi-LO LowLN diet groups (p≤0.05). In the HDL fraction, cholesterol esters were lower in the Hi-LO
group compared to Hi-LM, Hi-LO Low-LN and Hi-PO diet groups (p≤0.05). Also, Hi-LM
contained the lowest triglycerides compared with all other diet groups (p≤0.05) (Table 34).
Small LDL particles are considered a high risk for atherosclerosis compared to
larger LDL particles [29]. On the other hand, small HDL particles are considered more
cardio-protective compared with larger HDL particles [78]. Analyses of particle
diameters revealed, LDL particle diameter for Hi-LO Low-LN was significantly smaller
compared to Hi-PO diet group (p≤0.05). Also, Hi-LM and Hi-LO showed significantly
smaller HDL particle diameter compared to Hi-LO Low-LN, Hi-PO and Hi-OL diet groups
(p≤0.05) (Figure 3-13). CETP transfers cholesterol esters from HDL to VLDL and LDL in
exchange for triglycerides. Hamsters show CETP activity similar in humans and
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therefore present a good model to understand the changes seen in the LDL and HDL
fractions in the triglyceride and cholesterol esters.

Liver lipids Analyses
Experiment 1- Pilot Gerbil Study
Analyses of the liver revealed a no significant differences between the diet
groups for total cholesterol and free cholesterol. Cholesterol esters were calculated
as a difference between total cholesterol and free cholesterol. No significant
differences were seen for cholesterol esters between the diet groups (Table 3-5).
Experiment 2- Gerbil Study
Analyses of the liver revealed no significant differences between the diet
groups for total cholesterol, free cholesterol and cholesterol esters except total
cholesterol between Hi-LM and Hi-LO Low-LN diet groups (Table 3-6).
Experiment 3- Hamster Study
Analyses of the liver revealed no significant differences between the diet
groups for total cholesterol, free cholesterol and cholesterol (Table 3-7).

Expression of the Reverse Cholesterol Transport genes
RNA was isolated from the hamster liver and cDNA was synthesized using
random primers. Real time PCR was performed for reverse cholesterol transport
genes, namely, ABCA1, ApoA1, CETP and SR-B1 using specific primers. GAPDH
was used as an endogenous control. Relative gene expression was computed to
determine fold change compared to Hi-LM (positive control).
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Relative to Hi-LM diet all diets showed 2 fold decreased gene expression for
ABCA1 (Figure 3-14).
Relative to Hi-LM diet all diet groups showed increased gene expression for
ApoA1 with Hi-OL showing 2.2 fold increase compared to the Hi-LM group and 1.5
fold increase compared to other diet groups (Figure 3-14).
Relative to Hi-LM diet group Hi-LO Low-LN showed similar gene expression,
Hi-LO and Hi-PO showed almost 2.5 fold decrease in gene expression compared to
Hi-LM diet group. Hi-OL on the other hand showed a 2.6 fold increase in expression
for CETP relative to Hi-LM diet group (Figure 3-14).
The gene expression for SR-B1 decreased almost 2.5 fold for Hi-LO Low-LN,
Hi-LO and Hi-PO diet groups whereas Hi-OL showed similar gene expression for SRB1 compared with Hi-LM (Figure 3-14).
To summarize, the results of feeding dietary fats with higher saturation in
gerbils revealed that gerbils showed changes in TC ranging from 99 to 306mg/dL
(184±45) suggesting the effectiveness of the model to fatty acid sensitivity.
Compared with Hi-LM, all diets showed decrease in TC and HDL-C. All test diets with
higher dietary fat saturation had similar plasma and liver lipid profiles.
The results of feeding study in hamsters revealed changes in TC in Hi-LO
Low-LN, Hi-PO and Hi-OL were lower compared with Hi-LM and Hi-LO and HDL-C
was lower in Hi-PO and Hi-OL compared with Hi-LM and Hi-LO. There were no
significant differences in TC: HDL-C ratio and TG between the diet groups.
Lipoprotein TG composition was significantly different between diet groups for LDL
and HDL particles. In the HDL particles, CE was significantly lower in case of Hi-LO
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compared with Hi-LM, Hi-LO Low-LN and Hi-PO. There were no significant
differences observed in liver lipids between the diet groups. Relative fold differences
were observed in the expression of the RCT genes between the diet groups
compared to Hi-LM.

Specific Aim 2
The second objective of the study was to examine the extent to which the
amount and type of Saturated Fatty acids affect lipoproteins. Since hamsters are
shown to depict human lipoprotein metabolism, they were chosen as the model of
evaluation for the study.

Diet Given and Consumed
In order to see the effects in response to type and amount of the saturated fatty
acids, pelleted diet was fed to the hamsters. Food intake was monitored every two to
three days. After a week of acclimatization, the hamsters were randomly assigned to
one of the feeding groups - Lauric and Myristic Acid supplemented diet with varying
percentage of fat - 60%LM (n=15), 45%LM (n=15), 30%LM (n=15); 21%CON (n=15);
and Palmitic Acid supplemented group with varying percentages of fat - 30%PA (n=15),
45%PA (n=15). Over the 7 week feeding period, there were no significant differences in
amount of food provided between the diet groups. Analyses of diet consumed revealed
a significant higher consumption of food intake for 45%LM diet group compared with
60%LM and 45%PA. Food consumption in other diet groups was not significantly
different (Figure 3-15).
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For the study, diets were formulated such that percentage of calories from
protein, monounsaturated fatty acids and polyunsaturated fatty acids were kept constant
while calories from fat were replaced with calories from carbohydrate. 60%LM provided
the highest and 21% CON the least kcalories among the diet groups. Kcalories from
diets containing 45%fat were significantly higher than 30% fat (Figure 3-16). Analyses of
kcalories consumed revealed kcalories consumed for 60% and 45% LM diet groups was
significantly higher compared to all other diet groups. 21% CON group consumed lesser
kcalories compared to 45%PA, but there were no significant differences in the kcalories
consumed between 21%CON and 30% fat diet groups (Figure 3-16).

Body Weight and growth patterns were similar between all diet groups.
There was a progressive increase in body weight with age for all diet groups
over the 7 week feeding period indicating the adequacy of the diets with the trend
indicating the highest increase in body weight for 45% fat diet groups compared with
other diet groups. Even though there was a trend observed, the changes did not
show significant differences (Figure 3-17).
There were no significant differences in the initial body weight, but the final
body weight for 21%CON diet was significantly lower than the 45%LM diet group
reflected as a change in body weight (Figure 3-18). The change is body weight was
not significantly different between the other diet groups. Plotting the kcalories
consumed against change in body weight revealed that with an increase in the
consumption of kcalories, there was a linear increase in the change in body weight
(Figure 3-19).
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Liver weight (n=48) and Liver weight to body weight (n=48) ratios did not differ
significantly between the six diet groups (Table 3-8).

Plasma Total Cholesterol, n-HDL-Cholesterol and Triglycerides
To fully elucidate the effects of the amount and type of saturated fatty acid,
plasma and liver lipid profiles for 48 hamsters were examined. The 48 hamsters were
randomly chosen based on their final body weights. Analyses of plasma revealed that
the mean plasma TC (Figure 3-34) was significantly higher in the 60%LM compared
with all diet groups except 45%LM (p≤0.05). Also the hypercholesterolemic effect
was higher in 45%LM compared with 21%CON, and PA supplemented groups. Mean
plasma HDL-C (Figure 3-35) was significantly lower in 21%CON compared with
60%LM, 45%LM and 45%PA diet groups (p≤0.05). Plasma nHDL-C (Figure 3-36)
was significantly higher in the 60%LM compared with all diet groups except 45%LM
(p≤0.05). Also, nHDL-C was higher in 45%LM compared with 21%CON, and PA
supplemented groups. TC:HDL-C and nHDL-C:HDL-C ratios did not differ
significantly between the diets (Table 3-9).
Mean plasma triglycerides (Figure 3-34) were significantly different between
the 60%LM and 21%CON diet groups (p≤0.05). Triglycerides were higher in all diets
compared with 21%CON, but they did not reach significance.

Lipoprotein Fraction Analyses
CETP transfers cholesterol esters from HDL to VLDL and LDL in exchange for
triglycerides. Hamsters show CETP activity similar in humans and therefore can help in
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better understanding of the changes for the LDL and HDL fractions in TG and CE. To
fully elucidate the changes, plasma lipoproteins were separated using sequential
ultracentrifugation. Three lipoprotein fractions were isolated using density cuts of
lipoproteins for humans, namely, VLDL/IDL (1.006-1.019 g/mL), LDL (1.019-1.055
g/mL) and HDL (1.055-1.21 g/mL). For each fraction, total cholesterol, triglycerides, free
cholesterol, phospholipids and protein were determined. Cholesterol esters were
computed as a difference in total and free cholesterol.
In the VLDL fraction, free cholesterol was higher for 60%LM compared with PA
supplemented diets. Also, compared to 30%PA, 45%LM showed a significant increase
in free cholesterol (p≤0.05). Cholesterol esters were lowest in the 45%PA group
compared with all other diet groups (p≤0.05). Protein showed highest increases for
30%PA compared with all other diet groups (p≤0.05) (Table 3-10). Total cholesterol in
the VLDL fraction was significantly higher for 60%LM compared to 30% fat and 45% PA
diet groups (Table 3-11).
In the LDL fraction, triglycerides were lowest in the 60%LM diet group compared
with all other diet groups (p≤0.05). Also, 60%LM showed highest increases in
cholesterol esters, but did not show a significant difference (Table 3-10). Total
cholesterol in the LDL fraction was significantly higher for 60%LM compared to all diet
groups (Table 3-11).
In the HDL fraction, 60%LM showed highest triglycerides and protein compared
with all other diet groups, but significant lower phospholipids level compared with all
diets except 45%LM (p≤0.05) (Table 3-10). Total cholesterol in the HDL fraction was
significantly higher for 60%LM compared to 30% LM diet group (Table 3-11).
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Particle diameters
Small LDL particles are considered a high risk for atherosclerosis compared to
larger LDL particles [29]. On the other hand, small HDL particles are considered more
cardio-protective compared with larger HDL particles [78]. Analyses of particle
diameters revealed no significant differences between the diet groups (Figure 3-22).

Liver lipids Analyses
Analyses of the liver revealed no significant differences between the diet
groups for total cholesterol, free cholesterol between the diet groups. Cholesterol
esters were computed as the difference between TC and FC. 30%PA showed
significantly higher CE compared with 45%LM (Table 3-12).

Expression of the Reverse Cholesterol Transport genes
RNA was isolated from the hamster liver and cDNA was synthesized using
random primers. Real time PCR was performed for reverse cholesterol transport
genes, namely, ABCA1, ApoA1, CETP and SR-B1 using specific primers. GAPDH
was used as an endogenous control. Relative gene expression was computed to
determine fold change compared to 21%CON (positive control).
Relative to 21% CON, 60%LM, 30% LM, 30% PA and 45% PA showed similar
gene expression for ABCA1 whereas 45% LM showed 2 fold decreased gene
expression for ABCA1, relative to 21% CON (Figure 3-23).
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For ApoA1, 45% LM showed 2.8 fold increase in gene expression whereas
60%LM, 30%LM, 30%PA and 45% PA showed decreased gene expression with 30%
PA and 45% PA showing 6 and 4.3 fold decrease in expression relative to 21% CON.
30% PA and 45% PA showed 2 to 4 fold higher decrease in expression compared to
60% and 30% LM (Figure 3-23).
60%LM, 30% LM, 30% PA and 45%PA showed decreased gene expression
for CETP, relative to 21% CON. 60% LM and 45% PA showed a 3 fold decrease in
the expression for CETP compared to 21% CON and a 2 fold decrease compared
with 30% PA. 45% LM on the other hand showed a 2 fold increase in the expression
of CETP relative to 21%CON (Figure 3-23).
60% LM, 30% LM, and 30% PA showed similar gene expression for SR-B1
relative to 21% CON whereas 45% LM and 45% PA showed 2 fold decreased gene
expression relative to 21%CON. (Figure 3-23).
To summarize, the results from feeding diets with different type and amounts
of saturated fatty acids in hamsters revealed that kcalorie consumption was linearly
related to change in Body Weight. Plasma TC and n-HDL-C was lower in all diet
groups compared with 60%LM and 45% LM supplemented groups. No significant
difference in HDL-C and TC:HDL-C, nHDL: HDL ratio were observed between the
diet groups. 60% LM lipoprotein profile showed highest CE and lowest TG in the LDL
particle and low FC in the HDL particle compared with other groups. VLDL and LDL
fractions for 60% LM supplemented group carried the highest amounts of TC. Particle
sizes were not significantly different between the diet groups. Relative fold
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differences were observed in the expression of RCT genes between the diet groups
relative to 21%CON.
The gerbil and hamster studies (Specific Aim 1) showed no significant
differences in the lipid and liver profiles after feeding blended, genetically modified or
interesterified fat compared with naturally occurring coconut and soybean oil. Also,
feeding palmitic acid showed no adverse effects at 45% and 30% fat intake (Specific
Aim 2). These results led us to see the effects of these oils in human postprandial
state using an oral fat challenge (Specific Aim 3).

Specific Aim 3
The postprandial state is a reflection of the metabolic state in humans due to
regular diet intake. The third objective of the study was to evaluate postprandial
changes in lipids following an oral challenge to test oils - Linoleic acid rich soybean oil
(Hi-LO), Palm-Olein rich Palm oil (Hi-PO) and Oleic acid rich veggie fruit oil (Hi-OL) . 9
subjects started the study, but only 6 subjects completed the study with all the 3 diets.
The data presented is for n=6 who completed all the 3 oral fat challenges. The 3
subjects that are not included in the study were dropped out due to not completing all
the 3 diets. The human study was planned to be completed within the 4 months of the
semester, therefore, we could not have the subjects come in at a later time.
To elucidate the postprandial effects of the test oils, plasma lipids and lipoproteins
were analyzed. Triglycerides peaked at 2 hours after the ingestion of the test oil diets.
No significant differences were seen in the response of the test oil diets between the
diet groups at 0, 2, 4 and 8 hours. Mean plasma total cholesterol showed no significant
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differences between the three diets. There was a small non-significant increase in total
cholesterol from baseline at 2 hours, and then returned to baseline at 4 and 8 hours.
Mean plasma HDL-C showed no significant difference between the diets at 0, 2, 4 and 8
hours after the ingestion of the test fats (Table 3-13).
To evaluate the postprandial effects of dietary fatty acids on lipoproteins,
triglyceride rich fractions were isolated from plasma samples by sequential
discontinuous ultracentrifugation for each time point namely Sf > 400, Sf 60-400 and Sf
20-60. Analyses of the lipoprotein subfractions revealed no significant differences in the
triglyceride content between the test diet groups at 0, 2, 4 and 8 hours (Table 3-14).
CETP is active during triglyceridemic state. CETP activity was measured in
plasma at 0, 2, 4 and 8 hours. Analyses of the CETP activity in plasma revealed no
significant differences in activity between the diet groups at 0, 2, 4 and 8 hours.
To summarize, an oral fat challenge with Palm oil, Blended oil and Soybean oil
showed no significant difference in plasma lipids, chylomicron fractions and CETP
activity at 0, 2, 4 and 8 hours.

In Summary,


Specific Aim 1: In the animal models : no adverse effects were seen in the lipid
and lipoprotein profiles for the naturally occurring soybean oil, blended veggie oil,
genetically modified soybean oil and palm olein oil compared with coconut
supplemented diet- positive control

 Specific Aim 2: Palmitic acid supplemented diets showed improvement in TC and
n-HDL-C compared with the lauric and myristic supplemented groups.
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 Specific Aim 3: In the human study: No significant differences were seen in
plasma lipids with palm oil or blended veggie oil diets compared with soybean
diet.
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Table 3-1: Specific Aim 1: Experiment 1- Diet Consumed, Change in Body Weight
(BW) and Liver Weight for gerbils in the pilot study over 4 weeks feeding period

CHOW

Hi-LM

Hi-OL

Hi-LO

(n=3)

(n=6)

(n=6)

(n=6)

Diet Consumed (g)

6.7±0.6

5.2±0.4

5.3±0.5

5.2±0.4

Change in BW(g)

15±3.0

9±3.6

7±1.3

9±6.4

Liver Weight (g)

2.1±0.3

1.9±0.2

1.9±0.1

1.7±0.2

Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet using Coconut
oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or Linoleic Acid
supplemented diet using Soybean Oil (Hi-LO, n=6) for 4 weeks. Values are the Mean ± SD. For
comparative purposes, the values from 3 chow-fed gerbils are also shown (these animals were not
included in the statistical analyses). Data was analyzed using a one way analysis of variance (ANOVA).
• Gerbils were fed every 2-3 days. Diet consumed was estimated as the difference between diet
provided and spilled diet collected from the cage. There was no significant difference in the diet
consumed between the diet groups.
• Gerbils were weighed weekly. Change in body weight was taken as the difference in initial weight
and weight at the end of the 4 week feeding period. There were no significant differences in body
weight between the diet groups.
• Animals were sacrificed after 4 week feeding period. Livers were harvested and weighed. There
were no significant differences observed between the diet groups following the 4 week feeding
period.
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Table 3-2: Specific Aim 1: Experiment 2- Diet Consumed, Change in Body Weight
and Liver weight for gerbils after 4 weeks feeding period
CHOW

Hi-LM

Hi-SLO

Hi-LO

Hi-PO

Hi-OL

(n=15)

(n=15)

Low-LN
(n=4)

(n=13)

(n=15)

(n=13)

Diet Consumed (g)

6.5±0.1

4.7±0.4

5.2±0.2

4.8±0.1

4.6±0.2

5.0±0.3

Change in BW (g)

8±7.2

10±4.4

11±4.1

9±4.0

8±4.1

8±4.7

Liver Weight (g)

2.1±0.5

1.8±0.2

1.6±0.2

1.6±0.1

1.6±0.1

1.8±0.3

LW: BW ratio (%)

2.9±0.6

2.7±0.2a

2.4±0.1b

2.4±0.2b 2.6±0.2ab 2.7±0.3a

Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet using Coconut
oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic Acid
supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low Linolenic
Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented diet using Interesterified
Soybean Oil (Hi-SLO, n=15) for 4 weeks. Values are the Mean ± SD. For comparative purposes, the
values from 3 chow-fed gerbils are also shown (these animals were not included in the statistical
analyses). Data was analyzed using a one way analysis of variance (ANOVA).
• Gerbils were fed every 2-3 days. Diet consumed was estimated as the difference between diet
provided and spilled diet collected from the cage. There was no significant difference in the diet
consumed between the diet groups.
• Gerbils were weighed weekly. Change in body weight was taken as the difference in initial weight
and weight at the end of the 4 week feeding period. There were no significant differences in body
weight between the diet groups.
• Animals were sacrificed after 4 week feeding period. Livers were harvested and weighed. There
were no significant differences observed between the diet groups following the 4 week feeding
period.
• Liver weight to body weight ratio was significantly higher in Hi-LM and Hi-OL diet groups
compared to Hi-Lo Low-LN and Hi-PO diet groups. Diet groups in the same row sharing different
superscripts were significantly different from each other (p ≤ 0.05).
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Table 3-3: Specific Aim 1: Experiment 3- Diet Consumed, Change in Body Weight
and Liver weight for hamsters after 4 weeks of feeding period

Hi-LM

Hi-LO
Low-LN

Hi-PO

Hi-LO

Hi-OL

(n=15)

(n=15)

(n=15)

(n=15)

(n=15)

Diet Consumed (g)

5.7±0.6

6.2±0.4

5.9±0.4

6.1±0.6

6.2±0.5

Change in BW (g)

28±6.4

33±5.6

31±5.9

29±8.7

31±8.6

Liver Weight (g)

4.9±0.7

5.1±0.7

4.8±0.7

4.8±0.7

4.5±0.5

LW: BW ratio (%)

4.2±0.5

4.2±0.6

4.0±0.4

4.1±0.4

3.9±0.3

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic
Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low
Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (Hi-LO,
n=15) for 4 weeks. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance
(ANOVA).
• Hamsters were fed every 2-3 days. Diet consumed was estimated as the difference between diet
provided and spilled diet collected from the cage. There was no significant difference in the diet
consumed between the diet groups.
• The hamsters were weighed weekly. Change in body weight was taken as the difference in initial
weight and weight at the end of the 4 week feeding period. There were no significant differences
in body weight between the diet groups.
• Animals were sacrificed after 4 week feeding period. Livers were harvested and weighed. There
were no significant differences observed between the diet groups following the 4 week feeding
period.
• Liver weight to body weight ratio was not significantly different between the diet groups.
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Table 3-4: Specific Aim 1: Experiment 3 - Lipoprotein particle composition for
hamsters after 4 week feeding period

Hi-LM

Hi-LO

Hi-PO

Hi-LO

Hi-OL

Low-LN

VLDL
% FC

6.4±0.8

6.6±0.9

5.8±0.6

5.5±0.8

5.8±0.5

% CE

13.6±1.8

12.8±1.4

11.2±2.1

10.8±2.2

13.2±1.8

% TG

53.8±4.0

54.8±3.2

57.6±4.8

57.4±5.0

54.6±4.3

% PL

15.9±0.5

16.5±0.8

15.9±1.2

15.5±1.1

15.7±0.9

% Pro

10.2±1.6

9.3±1.0

9.4±1.5

10.8±2.6

10.7±1.5

% FC

5.8±1.8

5.9±1.9

5.1±1.2

7.3±0.7

5.5±1.1

% CE

27.1±4.5

27.0±3.5

29.5±1.4

29.5±0.9

29.1±2.7

% TG

10.6±1.8a

7.1±1.7b

10.2±1.2a

8.2±1.2b

7.6±1.3b

% PL

22.4±3.0

23.4±2.4

22.5±0.5

23.2±1.5

22.7±2.3

% Pro

34.1±3.2

36.5±7.4

32.6±2.2

31.8±1.7

35.1±2.1

2.9±1.0

3.3±0.6

LDL

HDL
% FC

3.6±1.0
a

19.6±1.6

a

19.6±1.0

3.9±0.8
a

16.9±0.6

2.6±0.9
b

18.0±2.2ab

% CE

19.1±0.4

% TG

0.7±0.1a

3.8±1.0b

3.5±1.9b

2.3±0.8b

5.3±1.4b

% PL

33.7±1.9a

31.4±1.4b

33.3±1.2a

31.9±1.0ab

30.3±1.7b

% Pro

42.9±2.5ab

42.3±2.1ab

40.3±1.7a

45.1±1.7b

43.8±3.1b

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic
Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low
Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (Hi-LO,
n=15) for 4 weeks. Plasma was isolated by centrifugation. Pooled plasma samples (3 - 4per each diet
group) were fractionated by sequential ultracentrifugation using the density cuts for humans - V+IDL
fraction (1.006<d<1.019g/ml), LDL fraction (1.019<d<1.055) and HDL fraction (1.063<d<1.21g/ml)
Fractions were Values are the Mean ± SD. Data was analyzed using a one way analysis of variance
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(ANOVA). There was no significant difference in the composition of the V+IDL fraction between the diet
groups. For LDL and HDL fractions, diet groups in the same row sharing different superscripts were
significantly different from each other (p ≤ 0.05).
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Table 3-5: Specific Aim 1: Experiment 1- Pilot Gerbil Study Liver Lipids (mg/g
liver) after 4 week feeding period
Liver lipids

CHOW

Hi-LM

Hi-OL

Hi-LO

(mg/g liver)

(n=3)

(n=6)

(n=6)

(n=6)

Total Cholesterol

4.5±1.0

5.8±0.3

5.9±0.8

6.9±1.5

Free Cholesterol

1.8±0.5

2.5±0.3

2.3±0.3

2.7±0.6

Cholesterol Esters

2.7±0.6

3.3±0.3

3.5±0.7

4.3±1.2

Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet using Coconut
oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or Linoleic Acid
supplemented diet using Soybean Oil (Hi-LO, n=6) for 4 weeks. Liver lipids were extracted using Folch’s
method. Total Cholesterol and Free cholesterol in the extracts were measured enzymatically. Cholesterol
esters were calculated by subtracting Free Cholesterol from Total Cholesterol. Values are the Mean ± SD.
For comparative purposes, the values from 3 chow-fed gerbils are also shown (these animals were not
included in the statistical analyses). Data was analyzed using a one way analysis of variance (ANOVA).
Liver lipids were not significantly different between the diet groups.
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Table 3-6: Specific Aim 1: Experiment 2- Gerbil Study Liver Lipids (mg/g liver) for
gerbils after 4 weeks feeding period
Liver lipids

CHOW

Hi-LM

Hi-SLO

(mg/g liver)

Hi-LO

Hi-PO

Hi-OL

(n=15)

(n=15)

Low-LN
(n=4)

(n=13)

(n=15)

(n=13)

Total Cholesterol

2.4±0.3

3.2±0.4a

Free Cholesterol

1.9±0.1

2.3±0.3

2.6±0.3

2.6±0.4

2.6±0.3

2.5±0.3

Cholesterol Esters

0.5±0.2

0.9±0.5

0.9±0.4

1.1±0.4

1.0±0.5

0.9±0.5

3.4±0.4ab 3.7±0.4b

3.6±0.4ab 3.4±0.5ab

Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet using Coconut
oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic Acid
supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low Linolenic
Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented diet using Interesterified
Soybean Oil (Hi-SLO, n=15) for 4 weeks. Liver lipids were extracted using Folch’s method. Total
Cholesterol and Free cholesterol in the extracts were measured enzymatically. Cholesterol esters were
calculated by subtracting Free Cholesterol from Total Cholesterol. Values are the Mean ± SD. For
comparative purposes, the values from 3 chow-fed gerbils are also shown (these animals were not
included in the statistical analyses). Data was analyzed using a one way analysis of variance (ANOVA).
No significant differences were seen in the liver lipids between the diet groups.
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Table 3-7: Specific Aim 1: Experiment 3- Liver Lipids (mg/g liver) for hamsters
after 4 week feeding period
Liver lipids

Hi-LM

(mg/g liver)

Hi-LO

Hi-PO

Hi-LO

Hi-OL

Low-LN
(n=15)

(n=15)

(n=15)

(n=15)

(n=15)

Total Cholesterol

3.7±0.5

3.9±0.4

3.8±0.5

4.0±0.6

3.9±0.5

Free Cholesterol

1.6±0.5

1.8±0.4

1.6±0.5

1.7±0.9

1.7±0.4

Cholesterol Esters

2.2±0.5

2.1±0.6

2.2±0.6

2.2±0.9

2.2±0.5

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic
Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using Low
Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (Hi-LO,
n=15) for 4 weeks. Liver lipids were extracted using Folch’s method. Total Cholesterol and Free
cholesterol in the extracts were measured enzymatically. Cholesterol esters were calculated by
subtracting Free Cholesterol from Total Cholesterol. Values are the Mean ± SD. Data was analyzed using
a one way analysis of variance (ANOVA). No significant differences were seen in the liver lipids between
the diet groups following the 4 week feeding period.
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Table 3-8: Specific Aim 2: Body Weight and Liver Weight for hamster after 7
weeks feeding period
60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

Liver Weight (g)

5.7 ± 0.7

6.3 ± 0.9

5.5 ± 1.0

5.7 ± 1.0

5.4 ± 1.0

5.7 ± 1.1

LW/BW (%)

4.1± 0.3

4.3 ± 0.4

4.0 ± 0.5

4.3 ± 0.6

3.9 ± 0.5

4.1 ± 0.5

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet with
varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA).
• Animals were sacrificed after 4 week feeding period. Livers were harvested and weighed. There
were no significant differences observed between the diet groups following the 7 week feeding
period.
• Liver weight to body weight ratio was not significantly different between the diet groups.
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Table 3-9: Specific Aim 2: Plasma lipoprotein ratios in hamsters after 7 weeks
feeding period
60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

TC:HDL-C

7.7 ± 1.5

7.2 ± 0.8

7.2 ± 0.8

8.4 ± 0.9

7.0 ± 1.7

7.3 ± 0.9

nHDL: HDL-C

6.7 ± 1.5

6.2 ± 0.8

6.2 ± 0.8

7.4 ± 0.9

6.0 ± 1.7

6.3 ± 0.9

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet with
varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and Palmitic
Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7 weeks.
Values are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA).
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Table 3-10: Specific Aim 2: Lipoprotein particle composition in hamsters after 7
weeks feeding period
60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

% FC

7.0±0.5a

6.7±0.5a

6.5±0.3ab

5.9±0.5ab

5.4±0.6b

5.7±1.0b

% CE

14.4±2.7a

12.4±1.8a

14.2±1.2a

14.2±2.7a

11.3±1.0a

7.6±3.3b

% TG

53.0±4.6a

55.7±2.9a

53.0±2.2a

51.8±6.7a

48.8±5.3b

56.2±6.9a

% PL

14.2±0.8

14.5±0.9

14.3±0.4

13.3±0.9

12.9±1.4

13.4±1.8

% Pro

11.4±2.4

10.6±1.7

12.0±0.9

14.8±3.3

21.6±6.0

17.1±5.4

% FC

10.1±0.9

8.9±2.8

7.2±3.1

7.0±3.3

7.8±1.7

11.3±1.7

% CE

30.1±1.0

25.3±4.4

24.1±4.6

25.8±2.1

23.9±1.3

20.5±1.4

% TG

8.6±0.5a

9.8±1.2b

10.8±0.7b

13.8±0.2b

12.9±0.6b

12.8±2.3b

% PL

22.3±2.1

21.7±4.5

20.3±5.4

21.8±6.9

23.7±2.8

24.5±2.5

% Pro

28.8±1.0

34.5±11.1

37.7±12.8

31.6±11.7

31.7±5.2

30.8±2.6

% FC

4.3±0.5a

5.1±0.5b

5.6±0.5ab

5.4±0.3ab

5.3±0.4ab

5.2±0.6ab

% CE

20.1±3.6

21.8±5.2

18.1±0.3

19.1±0.2

19.4±0.8

19.1±1.6

% TG

2.5±0.4a

1.4±0.2b

1.3±0.2b

1.4±0.2b

1.4±0.2b

1.3±0.1b

% PL

25.1±8.4a

33.2±3.9ab 36.0±1.3b

35.2±1.4b

35.6±1.2b

36.6±1.0b

% Pro

48.0±4.9a

38.6±6.1a

38.8±1.5a

38.3±2.2a

37.8±1.2b

VLDL

LDL

HDL

37.9±1.9a

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet with
varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and Palmitic
Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7 weeks.
Plasma was isolated by centrifugation. Pooled plasma samples (4per each diet group) were fractionated
by sequential ultracentrifugation using the density cuts for humans - V+IDL fraction (1.006<d<1.019g/ml),
LDL fraction (1.019<d<1.055) and HDL fraction (1.063<d<1.21g/ml) Fractions values are the Mean ± SD.
Data was analyzed using a one way analysis of variance (ANOVA). For the lipoprotein fractions, diet
groups in the same row sharing different superscripts were significantly different from each other (p ≤
0.05).
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Table 3-11: Specific Aim 2:Total Cholesterol (mg/dL) in lipoproteins in hamsters
after 7 weeks feeding period

60%LM

45%LM

VLDL

29 ± 5.6a

LDL
HDL

30%LM

21%CON

30%PA

45%PA

19 ± 4.7ab 18 ± 1.8b

19 ± 6.3ab

16 ± 3.7b

18 ± 3.9b

34 ± 5.2a

20 ± 3.8b

13 ± 3.0b

14 ± 3.8b

15 ± 1.4b

41 ± 8.1a

55±11.6ab 59 ± 7.2b

48 ± 7.7ab

55 ± 7.1ab

58 ± 1.5ab

(mg/dL)

14 ± 3.8b

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet with
varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and Palmitic
Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7 weeks.
Plasma was isolated by centrifugation. Pooled plasma samples (4per each diet group) were fractionated
by sequential ultracentrifugation using the density cuts for humans - V+IDL fraction (1.006<d<1.019g/ml),
LDL fraction (1.019<d<1.055) and HDL fraction (1.063<d<1.21g/ml). Total cholesterol in the fractions was
measured enzymatically. Values are the Mean ± SD. Data was analyzed using a one way analysis of
variance (ANOVA). For the lipoprotein fractions, diet groups in the same row sharing different
superscripts were significantly different from each other (p ≤ 0.05).
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Table 3-12: Specific Aim 2: Liver Lipids (mg/g liver) for hamsters after 7 weeks
feeding period
Liver lipids

60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

(mg/g liver)

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

(n=8)

Total Cholesterol

5.2 ± 0.9

4.9 ± 1.3

4.5 ± 0.5

5.2 ± 1.2

5.5 ± 1.1

5.3 ± 1.6

Free Cholesterol

3.9 ± 0.8

3.8 ± 1.2

3.0 ± 0.8

3.8 ± 0.8

3.8 ± 1.2

3.8 ± 1.7

Cholesterol Esters

1.3±0.5ab 1.1 ± 0.5a 1.5±0.4ab 1.5±0.5ab

1.7 ± 0.6b 1.5±0.3ab

Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet with
varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and Palmitic
Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7 weeks.
Liver lipids were extracted using Folch’s method. Total Cholesterol and Free cholesterol in the extracts
were measured enzymatically. Cholesterol esters were calculated by subtracting Free Cholesterol from
Total Cholesterol. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance
(ANOVA). No significant differences were seen in the liver lipids between the diet groups for total
cholesterol and free cholesterol. For Cholesterol esters, diet groups in the same row sharing different
superscripts were significantly different from each other (p ≤ 0.05).
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Table 3-13: Specific Aim 3: Plasma Lipids at 0, 2, 4 and 8 hours following the oral
fat challenge

Plasma Lipids
(mg/dL plasma)

Hi-PO
(n=6)

Hi-LO
(n=6)

Hi-OL
(n=6)

88 ± 21.0
173 ± 44.0
123 ± 17.9
54 ± 11.2

82 ± 39.9
146 ± 73.8
137 ± 44.8
59 ± 22.0

80 ± 28.7
187 ± 81.4
128 ± 55.9
54 ± 18.3

183 ± 36.6
191 ± 38.5
190 ± 36.3
181 ± 28.6

189 ± 16.9
195 ± 23.1
187 ± 23.4
188 ± 24.3

190 ± 31.0
200 ± 43.7
191 ± 35.5
188 ± 32.8

54 ± 16.1
52 ± 13.2
52 ± 13.4
56 ± 16.3

56 ± 14.0
56 ± 15.3
55 ± 13.3
58 ± 15.0

55 ± 17.8
60 ± 15.3
58 ± 15.0
60 ± 16.6

hours
Triglycerides
0
2
4
8
Total Cholesterol
0
2
4
8
HDL-C
0
2
4
8

Subjects were given an oral fat challenge with either Linoleic Acid supplemented fat using soybean oil Hi-LO (n=6), Palmitic acid supplemented fat using Palm Olein - Hi-PO (n=6) or Oleic acid supplemented
fat using Veggie fruit oil - Hi-OL (n=6) with a 2 week wash out period between each challenge. Blood
was collected at 0, 2, 4 and 8 hours. Plasma was isolated by centrifugation. Triglycerides and Total
Cholesterol were measured enzymatically. Following precipitation of apoB lipoproteins, HDL-C was
measured enzymatically. Values are the Mean ± SD. Data was analyzed using a one way analysis of
variance (ANOVA). There were no significant differences in the plasma lipids at 0, 2, 4 and 8 hours
between the diets.
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Table 3-14: Specific Aim 3: Plasma Lipoprotein Subfractions for Postprandial
Human Study

Plasma Lipids
(mg/dL plasma)
hours

Hi-PO
(n=6)

Hi-LO
(n=6)

Hi-OL
(n=6)

0

1.2 ± 0.7

1.8 ± 1.2

1.2 ± 0.5

2

7.7 ± 7.1

6.7 ± 5.5

8.4 ± 4.1

4

4.3 ± 1.6

7.8 ± 3.8

5.3 ± 4.1

8

1.4 ± 0.7

1.8 ± 0.8

1.7 ± 1.5

0

8.5 ± 3.1

6.5 ± 3.5

9.1 ± 4.5

2

14.7 ± 13.8

15.7 ± 14.0

19.6 ± 10.6

4

9.0 ± 4.7

13.4 ± 6.0

12.0 ± 3.4

8

3.0 ± 0.8

3.9 ± 2.2

4.8 ± 4.2

0

9.6 ± 3.8

7.5 ± 4.8

9.0 ± 2.5

2

12.9 ± 10.9

10.7 ± 7.2

17.5 ± 7.6

4

13.5 ± 4.1

14.4 ± 10.2

10.9 ± 2.8

8

4.1 ± 1.4

5.5 ± 3.3

4.7 ± 3.3

Sf > 400

Sf 60- 400

Sf 20- 60

Subjects were given an oral fat challenge with either Linoleic Acid supplemented fat using soybean oil Hi-LO (n=6), Palmitic acid supplemented fat using Palm Olein oil - Hi-PO (n=6) or Oleic acid
supplemented fat using Veggie fruit oil - Hi-OL (n=6) with a 2 week wash out period between each
challenge. Blood was collected at 0, 2, 4 and 8 hours. Plasma was isolated by centrifugation and lipid
concentrations were measured enzymatically. To fully characterize the postprandial effects of dietary
blends on lipoproteins, TAG rich fractions (Sf > 400, Sf 60-400 and Sf 20-60) were isolated from plasma
samples by sequential discontinuous ultracentrifugation for each time point. Triglycerides in the fractions
were measured enzymatically. Values are the Mean ± SD. Data was analyzed using a one way analysis
of variance (ANOVA). There were no significant differences in the lipoprotein subfractions at 0, 2, 4 and 8
hours between the diet groups.
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Figure 3-1. Specific Aim 1: Experiment 3: Growth in hamsters over 4 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein Oil (Hi-PO, n=15), Linoleic Acid supplemented diet
using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean
Oil (Hi-LO, n=15) for 4 weeks. Values are the Mean ± SD. Data was analyzed using a one way analysis of
variance (ANOVA). There was no significant difference in the growth of hamsters between the diet groups
over the 4 week feeding period.
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Figure 3-2. Specific Aim 1: Experiment 1: Plasma Total Cholesterol and HDL-C after 4 weeks
feeding period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or
Linoleic Acid supplemented diet using Soybean Oil (Hi-LO, n=6) for 4 weeks. Plasma was isolated by
centrifugation. Total Cholesterol was measured enzymatically. Following precipitation of apoB
containing lipoproteins, HDL-C was measured enzymatically. Values are the Mean ± SD. Data was
analyzed using a one way analysis of variance (ANOVA). Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05). For comparative purposes, the values from 3 chowfed gerbils are also shown (these animals were not included in the statistical analyses).
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Figure 3-3. Specific Aim 1: Experiment 1: TC to HDL-C ratio after 4 weeks feeding period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or
Linoleic Acid supplemented diet using Soybean Oil (Hi-LO, n=6) for 4 weeks. TC: HDL-C ratio is a
more sensitive risk marker for dyslipidemia. Values are the Mean ± SD. Data was analyzed using a
one way analysis of variance (ANOVA). Diet groups sharing different letters were significantly different
from each other (p ≤ 0.05). For comparative purposes, the values from 3 chow-fed gerbils are also
shown (these animals were not included in the statistical analyses).
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Figure 3-4. Specific Aim 1: Experiment 1: Plasma Triglycerides in gerbils after 4 weeks feeding
period for the pilot study
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=6), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=6) or
Linoleic Acid supplemented diet using Soybean Oil (Hi-LO, n=6) for 4 weeks. Plasma was isolated by
centrifugation and triglycerides were measured enzymatically. Values are the Mean ± SD. Data was
analyzed using a one way analysis of variance (ANOVA). Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05). For comparative purposes, the values from 3 chowfed gerbils are also shown (these animals were not included in the statistical analyses).
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Figure 3-5. Specific Aim 1: Experiment 2: Plasma Total Cholesterol and HDL-C in gerbils after 4
weeks feeding period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein Oil (Hi-PO, n=15), Linoleic Acid supplemented diet
using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented
diet using Interesterified Soybean Oil (Hi-SLO, n=15) for 4 weeks. Plasma was isolated by
centrifugation. Total Cholesterol was measured enzymatically. Following precipitation of apoB
containing lipoproteins, HDL-C was measured enzymatically. Values are the Mean ± SD. Data was
analyzed using a one way analysis of variance (ANOVA). Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05). For comparative purposes, the values from 4 chowfed gerbils are also shown (these animals were not included in the statistical analyses).
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Figure 3-6. Specific Aim 1: Experiment 2: TC to HDL-C ratio in gerbils after 4 weeks feeding period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein Oil (Hi-PO, n=15), Linoleic Acid supplemented diet
using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented
diet using Interesterified Soybean Oil (Hi-SLO, n=15) for 4 weeks. TC: HDL-C ratio is a more sensitive
risk marker for dyslipidemia. Values are the Mean ± SD. Data was analyzed using a one way analysis
of variance (ANOVA). Diet groups sharing common letters were significantly different from each other
(p ≤ 0.05). For comparative purposes, the values from 3 chow-fed gerbils are also shown (these
animals were not included in the statistical analyses). There were no significant differences observed
in the TC:HDL-C ratio between the diet groups.
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Figure 3-7. Specific Aim 1: Experiment 2: Plasma Triglycerides in gerbils after 4 weeks feeding
period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein Oil (Hi-PO, n=15), Linoleic Acid supplemented diet
using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented
diet using Interesterified Soybean Oil (Hi-SLO, n=15) for 4 weeks. Plasma was isolated by
centrifugation and triglycerides were measured enzymatically. Values are the Mean ± SD. Data was
analyzed using a one way analysis of variance (ANOVA). Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05). For comparative purposes, the values from 3 chowfed gerbils are also shown (these animals were not included in the statistical analyses).
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Figure 3-8. Specific Aim 1: Experiment 3: Plasma Total Cholesterol and HDL-C in gerbils after 4
weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented
diet using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL,
n=15), Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented
diet using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using
Soybean Oil (Hi-LO, n=15) for 4 weeks. Plasma was isolated by centrifugation. Total Cholesterol was
measured enzymatically. Following precipitation of apoB containing lipoproteins, HDL-C was
measured enzymatically. Values are the Mean ± SD. Data was analyzed using a one way analysis of
variance (ANOVA). Diet groups sharing different letters were significantly different from each other (p
≤ 0.05).
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Figure 3-9. Specific Aim 1: Experiment 3: Total Cholesterol to HDL-C ratio in hamsters after 4
weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using
Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (HiLO, n=15) for 4 weeks. TC: HDL-C ratio is a more sensitive risk marker for dyslipidemia. Values are the
Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA). There were no significant
differences in the TC:HDL-C ratio between the diet groups.
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Figure 3-10. Specific Aim 1: Experiment 3: Plasma Triglycerides in hamsters after 4 weeks feeding
period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented
diet using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL,
n=15), Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented
diet using Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using
Soybean Oil (Hi-LO, n=15) for 4 weeks. Plasma was isolated by centrifugation and Triglycerides were
measured enzymatically. Values are the Mean ± SD. Data was analyzed using a one way analysis of
variance (ANOVA). There were no significant differences in plasma triglycerides following a 4 week
feeding period between the diet groups.
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Figure 3-11. Lipoprotein fractions designated based on density cuts.
Plasma was isolated by centrifugation and lipid concentrations were measured enzymatically. Pooled
plasma samples (3-4per each diet group) were fractionated by discontinuous ultracentrifugation.
Fractions were designated based on plasma density cuts d<1.018g/ml, 1.018<d<1.063g/ml and
d>1.063g/ml and denoted V+IDL, LDL and HDL respectively.
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Figure 3-12. Specific Aim 1: Experiment 2: Plasma Lipoproteins Analyses for gerbils after 4 weeks
feeding period
Male Mongolian gerbils (8wks of age) were fed Lauric and Myristic Acid supplemented diet using
Coconut oil (Hi-LM, n=13), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15), Palmitic
Acid supplemented diet using Palm Olein Oil (Hi-PO, n=15), Linoleic Acid supplemented diet using Low
Linolenic Soybean Oil (Hi-LO Low-LN, n=13), Stearic acid and Linoleic Acid supplemented diet using
Interesterified Soybean Oil (Hi-SLO, n=15) for 4 weeks. Plasma was isolated by centrifugation. Pooled
plasma samples (3-4per each diet group) were fractionated by discontinuous ultracentrifugation. Values
are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA).
(A) Composition of V+IDL fraction (d<1.018g/ml): No significant differences were observed in the
plasma lipoproteins in the VLDL fraction.
(B) Composition of LDL fraction (1.018<d<1.063): Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05).
(C) Composition of HDL fraction (d>1.063g/ml): Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05).
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Figure 3-13. Specific Aim 1: Experiment 3: Lipoprotein Particle Diameters for hamsters after 4
weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using
Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (HiLO, n=15) for 4 weeks. Plasma was isolated by centrifugation. Pooled plasma samples (3-4per each diet
group) were fractionated by sequential ultracentrifugation. Particle diameters were calculated from core to
surface ratio (Van Heek and Zilversmit). Values are the Mean ± SD. Data was analyzed using a one way
analysis of variance (ANOVA). Diet groups sharing different letters were significantly different from each
other (p ≤ 0.05).
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Figure 3-14. Specific Aim 1: Experiment 3: Expression of Reverse Cholesterol transport genes in
hamsters following 4 week feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
using Coconut oil (Hi-LM, n=15), Oleic Acid supplemented diet using Veggie Fruit Oil (Hi-OL, n=15),
Palmitic Acid supplemented diet using Palm Olein (Hi-PO, n=15), Linoleic Acid supplemented diet using
Low Linolenic Soybean Oil (Hi-LO Low-LN, n=15), Linoleic Acid supplemented diet using Soybean Oil (HiLO, n=15) for 4 weeks. RNA was isolated from the liver and cDNA was synthesized using random
primers. Real time PCR was performed using specific primers (4-5 samples per diet group). Ct values
were normalized using GAPDH as an endogenous control. Relative gene expression was calculated [2ˆ
(- (avg. (Ct gene of interest) - avg. (Ct Housekeeping gene)))]. The relative expression values were used to determine
fold changes in the test diet compared to Hi-LM (positive control). The figure shows the relative fold
difference for ABCA1, ApoA1, CETP and SR-B1 for all diet groups relative to Hi-LM.
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Figure 3-15. Specific Aim 2: Diet Given and Consumed by hamsters over 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. Diet consumed was estimated as the difference between diet provided and spilled diet collected
from the cage. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance
(ANOVA). There was no significant difference in the diet given (g) between the diet groups over the 7
week feeding period. For diet consumed, diet groups sharing different letters were significantly different
from each other (p ≤ 0.05).
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Figure 3-16. Specific Aim 2: Kcalories Given and Consumed by hamsters over 7 weeks feeding
period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA).
Diet groups sharing different letters were significantly different from each other (p ≤ 0.05).
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Figure 3-17. Specific Aim 2: Growth in hamsters over 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA).
There was no significant difference in the growth of hamsters between the diet groups over the 4 week
feeding period.
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Figure 3-18. Specific Aim 2: Change in Body weight in hamsters over 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. The hamsters were weighed weekly. Change in body weight was taken as the difference in initial
weight and weight at the end of the 7 week feeding period. Values are the Mean ± SD. Data was
analyzed using a one way analysis of variance (ANOVA). Diet groups sharing different letters were
significantly different from each other (p ≤ 0.05).
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Figure 3-19. Specific Aim 2: Change in Body Weight in hamsters with respect to Kcalories
consumed over 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=15); 45%LM (n=15), 30%LM (n=15) ; 21%CON (n=15); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=15); 45%PA (n=15) for 7
weeks. The hamsters were weighed weekly. Change in body weight was taken as the difference
dif
in initial
weight and weight at the end of the 7 week feeding period. Kcalories consumed were calculated by
multiplying kcal/g diet consumed.
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Figure 3-20. Specific Aim 2: Plasma Lipids in hamsters after 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented
diet with varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8);
and Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8)
for 7 weeks. Plasma was isolated by centrifugation and Total Cholesterol was measured
enzymatically. Following precipitation of apoB containing lipoproteins, HDL-C was measured
enzymatically. nHDL was calculated as a difference of Total Cholesterol and HDL-C. Values are the
Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA). Diet groups sharing
different letters were significantly different from each other (p ≤ 0.05).
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Figure 3-21. Specific Aim 2: Plasma Triglycerides for hamsters after 7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented
diet with varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8);
and Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8)
for 7 weeks. Plasma was isolated by centrifugation and Triglycerides were measured enzymatically.
Values are the Mean ± SD. Data was analyzed using a one way analysis of variance (ANOVA). Diet
groups sharing different letters were significantly different from each other (p ≤ 0.05).

101
45
40

Particle Diameter (nm)

35
30
25

VLDL
LDL

20

HDL

15
10
5
0
60%LM

45%LM

30%LM

21%CON

30%PA

45%PA

Figure 3-22. Specific Aim 2: Lipoprotein Particle Diameters in hamsters after 7 weeks feeding
period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7
weeks. Plasma was isolated by centrifugation. Pooled plasma samples (4per each diet group) were
fractionated by sequential ultracentrifugation. Particle diameters were calculated from core to surface
ratio (Van Heek and Zilversmit). Values are the Mean ± SD. Data was analyzed using a one way analysis
of variance (ANOVA). Diet groups sharing common letters were significantly different from each other (p ≤
0.05).
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Figure 3-23. Specific Aim 2: Expression of Reverse Cholesterol transport genes in hamsters after
7 weeks feeding period
Male Golden Syrian hamsters (6wks of age) were fed Lauric and Myristic Acid supplemented diet
with varying percentage of fat - 60%LM (n=8); 45%LM (n=8), 30%LM (n=8) ; 21%CON (n=8); and
Palmitic Acid supplemented group with varying percentages of fat; 30%PA (n=8); 45%PA (n=8) for 7
weeks. RNA was isolated from the liver and cDNA was synthesized using random primers. Real time
PCR was performed using specific primers (4-5 samples per diet group). Ct values were normalized using
GAPDH as an endogenous control. Relative gene expression was calculated [2ˆ (- (avg. (Ct gene of interest) avg. (Ct Housekeeping gene)))]. The relative expression values were used to determine fold changes in the test
diet compared to 21% CON (positive control). The figure shows the relative fold difference for ABCA1,
ApoA1, CETP and SR-B1 for all diet groups relative to 21% CON.
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Figure 3-24. Specific Aim 3: CETP activity at 0, 2, 4 and 8 hours following the oral fat challenge
Subjects were given an oral fat challenge with either Linoleic Acid supplemented fat using soybean
oil - Hi-LO (n=6), Palmitic acid supplemented fat using Palm Olein - Hi-PO (n=6) or Oleic acid
supplemented fat using Veggie fruit oil - Hi-OL (n=6) with a 2 week wash out period between each
challenge. Blood was collected at 0, 2, 4 and 8 hours. Plasma samples were used to analyze CETP
activity. Values are the Mean ± SD. Data was analyzed using a one way analysis of variance
(ANOVA).No significant differences were observed in CETP activity at 0, 2, 4 and 8 hours between the
diets.
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Chapter 4: Discussion
Consumption of partially hydrogenated vegetable oils (PHVO) containing transfatty acids (tFA) and saturated fatty acids (SFA) have been associated with higher
incidence of coronary heart disease. An attempt to eliminate PHVO from the food
supply has led to finding alternatives with higher dietary fat saturation compared to
naturally occurring vegetable oils. In the present study we evaluated the effects of
dietary fat saturation on lipoprotein metabolism using – High Linoleic soybean oil (HiLO), High Linoleic Low Linolenic Soybean Oil

(Hi-LO Low-LN), High Stearic and

Linoleic Soybean oil (Hi-SLO), High Oleic Oil Blend (palm, corn & sunflower) (Hi-OL)
and a palm oil fraction with an increased content of oleic acid (Hi-PO). Experimental and
observational data have established that consumption of PHVO containing tFA and SFA
lead to similar increases in total cholesterol and LDL-cholesterol (LDL-C). Also, among
individual SFA, lauric and myristic acids show the most increases in TC and LDL-C
compared to palmitic and stearic acids. Therefore, we used a diet high in Lauric and
Myristic acid (Hi-LM) as a positive control for our study. The effects of the diets were
evaluated in gerbil and hamster model since gerbils are highly sensitive to fatty acid
manipulations and hamsters are widely accepted as appropriate models to depict
human lipoprotein metabolism.
In gerbils and hamsters, amount of diet consumed was not significantly different
between the diet groups suggesting equal acceptance of the oils contained in the
pellets. In the 4 weeks of the study period, body weight increased for all gerbils and
hamsters in all the diet groups with no signs of illness or deficiency. The growth through
the span of the study is indicative of adequacy of the diet. Body weights did not differ
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significantly between the diet groups suggesting that isocaloric consumption of diets,
irrespective of the type of fat consumed may not have effects on body weight.
Liver weights were not significantly different between the diet groups for gerbils
or for hamsters. In the gerbil model, when body weight and liver weight were taken as a
ratio, Hi-SLO and Hi-LO Low-LN were significantly lower to Hi-LM and Hi-OL groups.
The differences seen seem to be a statistical artifact. The body weight reported was
taken during the feeding period of the study, whereas the liver weights are
representative of the fasting state. Also, a hind side of the study, we did not take the
absolute adipose weight for the gerbils. Therefore, it would be difficult to conclude why
these differences were observed.
Plasma TC in gerbils indicated changes ranging from 99 mg/dL to 306 mg/dL
(184 ± 45) establishing the effectiveness of the model to fatty acid sensitivity. Hi-LM
showed highest increase in TC compared with all other diet groups. Also, Hi-LM showed
maximum rise in HDL-C compared with other diet groups. In the LDL and HDL fractions
of plasma, Hi-LM contained the most amount of cholesterol compared with other diets.
Lauric acid has the greatest TC and HDL-C raising effect compared with other SFA,
MUFA and PUFA. This effect is even more pronounced in gerbils since almost 70% of
TC is carried in the HDL representing the major system for transport for cholesterol [71].
Plasma TC in hamsters indicated changes ranging from 123 mg/dL to 261 mg/dL (205 ±
27) establishing the effectiveness of the model to fatty acid sensitivity. Analyses of
plasma revealed that TC and HDL-C were significantly higher for Hi-LM and Hi-LO
compared with other diet groups. Increased TC and HDL-C in the case of Hi-LO group
is an unexpected result. In a study to evaluate the effects of different fatty acids by
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Lichtenstein et al, they also observed no significant differences between LM rich
Coconut oil and LO rich Soybean oil. At the same time, there were differences between
butter diet and soybean oil enriched diet. It is a highly plausible that there is a
differential effect of dietary fatty acid and their specific combinations on lipoprotein
metabolism. Based on these results however, it might not be correct to conclude that
consuming linoleic acid supplemented oils, as in case of soybean oil raises total and
HDL-Cholesterol.
Another aspect that warrants attention is that in the diets for gerbils and hamsters
compared to Hi-LM diet, PUFA to SFA (P:S) ratio was higher in all other diets. It could
be speculated, as shown earlier by Hayes et al, level of PUFA in the diet could be a
determinant of how the SFA affect lipoproteins [79].
In the gerbil model, plasma TG was also significantly higher in the Hi-LM diet
compared with all other diet groups. Amongst the lipoproteins, VLDL is the major carrier
for TG. In the gerbil model, Hi-LM diet contained the highest amount of TG in the VLDL
particle compared with all other diet groups. This is in line with documented results from
gerbil model studies where SFA raises TG relative to MUFA and PUFA diets [71]. In
the hamster model, plasma TG was not significantly different between the diet groups.
This observation was again an unexpected result based on data available on hamsters,
but it is also known that hamsters have mouth pouches where there is a possibility food
could remain. The standard deviation for TG (148 mg/dL ± 56) suggests that this
difference might be due to variation in fasting status of the hamster.
In the hamster model, analyses of lipoprotein revealed no significant differences
in the composition of the VLDL particle. In the LDL particle, TG increased in Hi-LM and
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Hi-PO compared with Hi-LO and Hi-LO Low-LN. Also, in the HDL particle TG was
lowest in Hi-LM compared to all diet groups and CE was lowest in Hi-LO compared with
other diet groups.
CETP transfers cholesterol esters from HDL to VLDL and LDL in exchange for
triglycerides. Hamsters show CETP activity similar in humans and therefore present a
good model to elucidate mechanisms associated with Reverse Cholesterol Transport
(RCT). In an attempt to understand the differences we saw in the LDL and HDL
lipoproteins, we analyzed the expression of RCT genes. Based on the results, in the
LDL particle, TG was highest in Hi-LM diet group along with being lowest in the HDL
particle along with higher CE. These analyses led to the speculation that CETP
expression might be altered with Hi-LM consumption. ABCA1, ApoA1, CETP and SRB1 in the liver tissue were explored and analyses were made using fold differences
between the diet groups relative to Hi-LM. The trend showed, compared to Hi-LM,
expression of CETP was almost 2.5 fold lower in soybean supplemented Hi-LO and
tropical oil fraction Hi-PO and 2.6 fold increased expression in blended oil Hi-OL.
Increased expression of CETP would suggest increased TG in the HDL and decreased
expression would indicate decreased TG in the HDL particles. The trend did not show
these differences in the TG and CE in the LDL and HDL lipoproteins. Based on
available literature, not much has been done to interpret our analyses to previous data.
Dorfman et al analyzed CETP activity in hamsters fed different dietary fatty acids, and
the results showed no difference in the activity [64]. More research is warranted to
explain the differences that we see in the plasma and lipoproteins in this study. Other
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pathways that might influence these differences need to be studied, especially LDL-C
pathway.
Mechanisms associated with increase in Plasma TC and LDL-C has been studied
in the gerbil and the hamster models. Gerbils are HDL models with almost 70% of the
cholesterol transported in the HDL particle as opposes to hamsters, which like humans,
exhibit the effects of dietary fatty acids in plasma through changes in LDL-C and
moderately through HDL-C. It is speculated that the changes seen in the plasma lipids
is due to either the alteration in the rate of LDL production or/and receptor dependent
LDL uptake by the liver [80]. SFA is associated with depressing the activity and
expression of LDL receptors, thereby increasing the concentration of circulating plasma
cholesterol. On the other hand, unsaturated FA tends to accelerate the rate of receptor
dependent LDL uptake resulting in lowering of circulating LDL concentrations [81]. Also,
the effect is more pronounced in the presence of dietary cholesterol. Dietary cholesterol
suppresses LDL receptors and SFA along with dietary cholesterol has a combined
effect on LDL receptor uptake, and PUFA tends to partially restore the suppression due
to dietary cholesterol [80]. Horton et al demonstrated that the changes induced due to
receptor dependent LDL transport paralleled changes in LDL receptor protein and
mRNA levels.
Along with LDL receptors, activity of ACAT is also known to increase with
unsaturated FA consumption. In contrast, SFA are speculated to inhibit ACAT activity
resulting in decreased conversion of FC to CE and thereby, increasing the FC pool. An
increase in FC pool mediated feedback repression of the LDL receptor pathway, further
intensifying the effects. There is little data available on the effects of blended,
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genetically modified and interesterified fats on these pathways relative to naturally
occurring oils. This would be an interesting venue for future studies to understand the
underlying mechanisms that control the changes in plasma cholesterol level at the level
of expression and how they in sync with the HDL regulation genes.
Small LDL particles are considered atherogenic compared to the larger LDL
particles and also there is emerging data that small HDL particles might have a pro
atherogenic effect. Based on Heek and Zilversmit formula for particle size
measurement, LDL and HDL particles showed significant differences between diet
groups in hamsters. To fully elucidate the effects of the diets on the particle size and
compositions, subfractions of the lipoproteins need to be evaluated. For the current
study we did not analyze the subfractions of LDL and HDL particles and the differences
we see are very small to conclude their effects.
Analyses of the liver lipids revealed no significant differences between the diet
groups in the gerbil and the hamster models. Studies comparing the effects of SFA and
unsaturated FA show decrease in liver lipids with SFA consumption [82, 83]. In the
hamster study, Hi-LM and Hi-LO diets induced similar plasma concentrations and
therefore, it may be speculated that liver lipids for both would be similar, although the
mechanisms may not be the same. Little is known about the effects of blended and
genetically modified oils on liver metabolism. More research is warranted to explain and
understand if these effects are reproducible and to what degree they apply to humans.
Saturated fatty acids (SFA) have been associated with increased CVD risk and
have been a subject of debate for establishing the recommendations of Dietary
Guidelines for the last 50 years. In terms of replacing SFA, Carbohydrates (CHO) are
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generally considered as a safe substitution. There is emerging data that SFA may not
pose adverse effects and there may not be any additional effects with SFA being
replaced by CHO. In the present study we examined the extent to which the amount
and type of SFA affect plasma lipids and lipoproteins. Diets were formulated such that
percentage of calories from protein, MUFA and PUFA were kept constant while calories
from Lauric and Myristic (60%LM, 45%LM, 30%LM) or Palmitic Acid (45%PA, 30%PA)
were replaced with calories from carbohydrate and compared to 21% CON diet. To
elucidate the effects, we used a hamster model, evaluated plasma and liver lipids and
analyzed the RCT gene expression for holistic understanding of the diets.
In the present study, diet consumed and body weights showed interesting
results. Diet consumed was highest for 45% LM group and interestingly, 45%PA and
60% LM diet groups consumed significantly lesser diet compared to 45%LM. One of the
plausible explanations could be that 45% LM had a higher acceptance for the diet
compared to 45%PA and 60%LM. Also, there could be a higher satiety effect of 45%PA
and 60%LM compared to 45%LM. Whether these effects are due to taste, palatability,
satiety or digestibility needs further investigation.
Based on the grams consumed, kcalories were affected likewise and analyses of
the results show that kcalories consumed were directly associated with increase in body
weight. Kcalorie consumption for 45%LM was higher compared to all diets, and the
trend revealed that 45%LM had the most weight gain, but change in weight was
significantly different only between 45% PA and 21% CON.
Results of plasma analyses showed that 60%LM and 45%LM raised plasma TC
and nHDL-C more than all other diets. But the most striking result was that 45%LM
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showed increases in TC and nHDL-C more than 45%PA without any significant
differences in HDL-C. Comparing the P:S ratio for these diets suggest plausible
explanations. It is speculated that P:S ratio close to 1 diminishes the effects of SFA on
plasma cholesterol. 21%CON and 30% fat diets had P:S ratios of 4.64 and 0.9
respectively, and consequently there were no significant differences in their plasma lipid
profile. 45%fat and 60%LM had P:S ratios of 0.4 and 0.23 respectively and it would be
expected that all three would show similar increases, but 45%PA showed significantly
lower plasma TC and nHDL-C compared with 45%LM and 60%LM, establishing a
higher cholesterolemic effect of Lauric and Myristic acid compared with Palmitic acid.
Also, as previously shown in studies, SFA has a higher potential to raise HDL-C
compared to unsaturated FA was verified in the present study too. 60% LM, 45%LM
and 45%PA revealed significantly higher HDL-C levels compared with the 21%CON
diet. Similar trend was seen with 30% LM and 30%PA compared to 21%CON, but the
differences did not reach significance.
Another aspect of understanding these results are in the light of the fact that
these diets represented replacement of SFA with CHO. Compared to a high CHO diet
(21%CON), all SFA diets showed increase in TC, nHDL-C as well as HDL-C with no
effect on TC:HDL-C ratio. This is in agreement with current literature suggesting that
due to the magnitude of changes between the lipoproteins in a high fat versus a high
CHO diet TC:HDL-C ratio is unaffected [30, 53]. Therefore, in this respect CHO
replacement of SFA, there seems to be no additional beneficial effect.
Predictive models and studies conducted in humans suggest replacement of SFA
with CHO suggest that a high CHO diet is likely to have higher TG compared with high
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SFA diet [52]. The present study revealed the opposite results. High CHO or 21% CON
diet showed lowest TG compared to all other diets in trend, although the differences
were only significant between 60%LM and 21%CON. In the present study, 21%CON
contained 21%, 54% and 25% energy from fat, CHO and protein respectively. In study
models used to assess differential effects of CHO on lipoprotein metabolism have used
CHO higher than 55% and fat higher than 30% [84]. Our study’s design even though
represents substitution of CHO for fat, was primarily set up to see the differential effects
of individual FA substitutions of lauric and myristic versus palmitic acid with respect to
CHO. Further research is warranted to understand the differential effects in TG
metabolism in high fat versus a high CHO diet.
Lipoprotein analysis revealed that in case of 60% LM, TG was lowest in the LDL
and highest in the HDL particles compared to all diets. The results suggest that there
might be a potential inhibitive role of CETP involved which we investigated as a part of
studying the RCT genes. Also, TC in VLDL and LDL were significantly higher in 60%LM
compared to all other diets. The results from the lipoprotein TC analyses need further
investigation to understand underlying mechanisms. A plausible explanation could be
that there is an increase in the secretion of the VLDL/LDL particles. Apo B is the specific
marker for number of VLDL/LDL particles or it could be that the number of particles is
the same but the lipoproteins have an increased concentration of TC. This could be due
to the suppressive effect of SFA on the LDL receptor and hence clearance of LDL-C.
Whether the effect of higher VLDL/LDL-C in 60%LM is due to increased synthesis or
decreased clearance needs further investigation.
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Liver weights were not significantly different between diets. Also analyses of liver
lipids revealed no significant differences in TC, FC and CE between the diet groups. It
would be interesting to investigate why no differences were observed. A plausible
thought could be that there is a suppressive effect of SFA on LDL receptors and an
increased clearance of FC due to up regulation of ACAT and 7-alpha hydroxylase in the
21%CON diet compared to other diet groups. Therefore, even if there is an increased
uptake of nHDL-C from the circulation, its clearance is also up regulated. The effects
could be explored further by investigating the expression of genes involved in LDL
metabolism.
To understand some of the differences seen in the lipoprotein composition and to
investigate the changes with replacing CHO for SFA, we looked at the expression of the
RCT genes in the liver tissue. The most striking differences were seen in the expression
of ABCA1, ApoA1, CETP and SR-B1 for the 45% LM diet group relative to 21%CON,
and compared to all other diet groups. The trend seemed to be working in the opposite
direction compared to all other diets. Plasma lipids and lipoproteins for 45% LM
behaved differently compared to 45% PA and similar to 60% LM. Further investigation is
warranted to understand the trends in the differences seen and if there are other
pathways that might be involved in the regulation.
The postprandial state represents the phase between food ingestion and the
post-absorptive state, and is the habitual metabolic state for most duration of the day.
Characteristic to this phase is the rise in TG and TG-rich lipoproteins, Chylomicrons and
VLDL of intestinal and hepatic origin respectively. For the present study we presented
an oral fat challenge in 6 healthy subjects to investigate the effects of an oleic and
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linoleic acid supplemented blended oil (Hi-OL), palm oil with a higher fraction of oleic
acid supplemented oil (Hi-PO) and high linoleic acid supplemented oil (Hi-LO) on
postprandial lipids and lipoproteins.
Analyses of the results show a rise in TG at 2 hours and slowly declining through
4 and 8 hours subsequently. No significant differences were observed between the diet
groups for TG, TC and HDL-C at 0, 2, 4 and 8 hours. A tropical oil based Hi-PO and
blended oil Hi-OL represent alternatives that can be used in place of PHVO and contain
higher dietary SFA compared to soybean oil, Hi-LO. Based on the results on plasma
lipids in this pilot study, it may be speculated that these alternatives can be used
interchangeably.
To further investigate the effects of these oils, we observed their effects on
CM/VLDL subfractions. Sf>400 is produced by the intestine and carries TG derived from
ingested fat. Analyses of the results reveal that Sf>400 increased substantially from 0 to
2 hours indicating the incorporation of TG in the chylomicron particle from fasting to fed
state. In sync with the plasma TG results, Sf>400 declined at 4 and 8 hours
subsequently. During the fed state, CM gets cleaved of TG and CM remnants are taken
up by the liver.
Sf 60-400 and Sf 20-60 represent chylomicron remnants in addition to hepatically
synthesized VLDL particles. Their hepatic origin can be justified by the fact that the level
of TG in these particles is higher in the fasting state compared with the CM Sf>400
particles. At 2 hours, Sf 60-400 increased in TG concentration and declined at 4 and 8
hours. For Sf 20-60, TG increased at 2 and 4 hours and then decreased at 8 hours.
Plausible explanation to these changes could be the shift in metabolic state of fed to
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early fasting. No significant differences were observed between the diet groups at any
time point. This further strengthens the idea that consumption of Hi-Po and Hi-OL will
not pose any adverse effects compared with Hi-LO.
CETP is active in the postprandial state. An increase in CETP activity is
considered to be atherogenic due to its potential to transfer cholesterol esters to
VLDL/LDL particles and thereby increasing the concentration of LDL-C. In the present
study, no significant changes in the CETP activity were observed between the diet
groups at any time point. The baseline CETP activity for individual subjects varied on
each study day. Therefore, these results from CETP activity need to be further
investigated in a larger population to derive conclusive results.
The results from the study suggest no adverse effects of the diets compared with
Hi-LO. But these results also need to be interpreted with caution. The number of
subjects in this pilot study are only suggestive of the direction, but cannot be used as
conclusive. There are some limitations to the study that need to be addressed that could
potentially impact the results of the study. The oral fat challenge was given as a
“smoothie” and the test oil was added to it. There was no way of measuring the level of
incorporation of the oil in the smoothie the left overs. The oil had the tendency to stick to
the sides of the blender and therefore complete ingestion of the amount is a concern.
Another limitation was the control on the subjects regarding the fasting period before the
study day. Even though the subjects were asked to maintain similar diets before the
study day and fast for 12 hours, there was no way of verifying these concerns.
In light of the above observations and limitations, it is evident that a larger study
is needed to evaluate the full potential of these alternative oils. The study needs to
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include a much larger population and should be a feeding study to see the complete
effects of these oils with increased dietary SFA on lipids and lipoproteins.
To Summarize
In the first study we evaluated the effects of naturally occurring oils (Coconut and
Soybean oils), interesterified fat, blended oil, palm oil fraction and a genetically modified
fat in a gerbil and hamster model. The results from the study suggest that compared to
the Hi-LM coconut oil diet, all diet formulations presented decrease in plasma lipids
irrespective of SFA formulations. No adverse effects were seen in terms of lipoprotein
composition or liver lipids. The present study agrees with the hypothesis that oil
formulations with specific SFA will not cause any adverse effects in lipids and
lipoproteins.
The second study was an attempt to investigate the differential effects of
replacing specific SFA with CHO on lipoprotein metabolism. The analysis of the study
shows higher cholestrolemic effect of lauric and myristic acid at 45% and 60% intake
compared with palmitic acid at 45%. Also for diets that maintain P:S ratio close to 1 did
not show any adverse effects on plasma lipoproteins. It would therefore be interesting to
speculate that if P:S ratio in a diet is maintained, SFA intake up to 30% would not have
any adverse effects. Also, replacement of SFA with CHO will induce no additional
benefit.
In the final study we evaluated the effects of a tropical oil fraction (Hi-PO) and a
blended oil (Hi-OL) in comparison to the most widely used oil source in the US,
Soybean oil (Hi-LO). The analyses of the study suggest no adverse postprandial effects
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of these oils on plasma lipids and lipoproteins. More research is warranted to explore
the potential effects of these oils in a larger population.
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Consumption of trans-fatty acids (tFA) and saturated fatty acids (SFA) have been
associated with higher incidence of coronary heart disease. Experimental and
observational data suggests that consumption of PHVO containing tFA, like SFA leads
to increased total cholesterol and LDL-cholesterol (LDL-C) but compared to tFA, SFA
raises HDL-cholesterol (HDL-C). An attempt to eliminate PHVO from the food supply
has resulted in the need to find alternatives which despite their higher dietary fat
saturation as compared to naturally occurring vegetable oils, may be preferable to
PHVO. However, amongst SFA, the effects on plasma lipoproteins are variable. Thus,
we hypothesized that specific combinations of dietary SFA will not contribute to an
adverse lipid profile.
We used gerbils and hamsters as our study models to determine the effects of
Lauric and Myristic Acid (Hi-LM), Oleic Acid (Hi-OL), Palmitic Acid (Hi-PO), Linoleic Acid
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(Hi-LO Low-LN), Stearic acid and Linoleic Acid (Hi-SLO) supplemented diets on plasma
and liver lipids and lipoproteins. The results revealed that compared to the Hi-LM diet,
all diets had lower TC, LDL-C and HDL-C. Liver lipids were similar for all the diet
groups. Also, we analyzed the gene expression for the reverse Cholesterol transport
genes. No significant differences in ABCA1, ApoA1, CETP or SR-B1 were observed
between the diet groups compared with Hi-LM diet. The data suggested no additional
adverse effects on CHD risk factors compared with Hi-LM diet.
Carbohydrates are generally considered a safe replacement for SFA. We used a
hamster model to evaluate the extent to which the amount and type of SFA affect
lipoproteins. Diets were formulated such that percentage of calories from protein, MUFA
and PUFA were kept constant while calories from Lauric and Myristic (60%LM, 45%LM,
30% LM) or Palmitic Acid (45%PA, 30% PA) were replaced with calories from
carbohydrate and compared to 21% CON diet. Plasma TC and n-HDL-C was lower in
all diet groups compared with 60%LM and 45% LM supplemented groups. Liver lipids
were similar in all diet groups. Analysis of Reverse Cholesterol Transport genes
revealed no significant differences in expression between the diet groups compared
with 21% CON. Data suggests no adverse effect of PA at any level of consumption and
no net effect of replacing CHO for at any level of SFA.
The postprandial state is a reflection of the metabolic state in humans due to
regular diet intake. We used an oral challenge to test oils with various fatty acid
compositions (Hi-PO, Hi-LO and Hi-OL) to evaluate postprandial changes in lipids at 0,
2, 4 and 8 hours. No significant differences were seen in TC, HDL-C, TC:HDL-C and TG
between the test oils. We analyzed the chylomicron fractions following the oral fat
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challenge and data revealed no significant differences in the chylomicron fractions
between the test oils. Additionally, we measured CETP activity in plasma following the
challenge and no significant differences were observed. The data suggests in
agreement with the hypothesis, oil formulations with specific SFA will not cause any
adverse effects in lipids and lipoproteins.
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